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Summary
The aims of this study were firstly to investigate the 
influence of the renin-angiotensin system on growth of various target 
tissues (kidney, adrenal gland and blood vessels). Secondly, to 
determine whether changes in growth were a direct consequence of 
trophic actions of angiotensin II (AH) or secondary to changes in blood 
pressure. Thirdly to investigate the interactions of the renin-angiotensin 
system with other factors (nitric oxide synthesis, glucocorticoid 
hormone) in the control of growth of target tissues.
In each group of rats bromodeoxyuridine (BrdUrd), a 
thymidine analogue, was given by subcutaneous infusion continuously 
for two weeks during vaiious treatments. The animals were killed and 
DNA synthesis was assessed histologically by calculating a BrdUrd 
index for each cell type. Kidney sections were immunocytochemically 
stained for renin content. Various morphometric measurements were 
made in adrenal and vascular tissues.
The renin-angiotensin system was manipulated in three 
ways: i) by infusing All subcutaneously, ii) by feeding a low or 
supplemented sodium diet, iii) by administering captopril in the drinking 
water. The role of nitric oxide in the regulation of DNA synthesis was 
investigated by treating rats for up to four weeks with an inhibitor of 
arginine synthase, L-NAME. The effect of glucocorticoid hormone was 
tested by implanting a dexamethasone pellet subcutaneously.
Blood Vessels:
In mesenteric blood vessels, All infusion increased 
blood pressure and stimulated DNA synthesis in the endothelium, media 
and adventitia of arteries. Compared with rats fed a sodium 
supplemented diet, rats given low sodium food had higher BrdUrd 
indices in all parts of the blood vessels. Captopril lowered the BrdUrd 
index in the media and adventitia but had no effect on the endothelium. 
Neither L-NAME nor dexamethasone significantly affected DNA 
synthesis in vascular smooth muscle cells. DNA synthesis in mesenteric 
veins was not affected by any treatment. Medial area in transverse 
sections of arteries was greater after All treatment. None of the other 
treatments caused vascular hypertrophy.
Adrenal Gland:
The BrdUrd indices of epithelial and non-epithelial cells 
were assessed separately in six areas of the adrenal gland: the zona 
glomerulosa, the zona intermedia, the outer and inner fasciculata, the 
zona reticularis and the adrenal medulla. All and low dietary sodium 
increased the BrdUrd index significantly in the zona glomerulosa and in 
the zona reticularis but had no effect on the zona fasciculata. Treatment 
with captopril caused zona glomerulosa atrophy but had no effect on the 
BrdUrd index. Captopril reduced DNA synthesis in the reticularis. 
There was hypertrophy of the zona glomerulosa after treatment with 
either All or low sodium whereas, high sodium, L-NAME, 
dexamethasone and captopril caused atrophy. Changes in the BrdUrd 
index in the medulla appeared to be controlled in a compensatory 
manner by blood pressure. Treatments which tend to increase blood 
pressure (All, dexamethasone, L-NAME) reduced the BrdUrd index 
whereas captopril caused an increase.
Kidney:
The number of renin secreting cells in the kidney was 
increased by low sodium and also by captopril. Despite the increase in 
the number of cells, there was no evidence of DNA synthesis in any 
renin-secreting cell. BrdUrd indices were calculated for glomerular, 
tubular and interstitial cells. All increased the BrdUrd index in 
glomerular cells, captopril caused an decrease but low and high dietary 
sodium, L-NAME and dexamethasone had no effect. Dexamethasone 
increased the BrdUrd index in tubule cells and L-NAME increased DNA 
synthesis in interstitial cells. All, captopril or dietary sodium 
manipulation had no effect on DNA synthesis in tubules or interstitial 
cells.
Conclusions:
The control of growth of the cardiovascular system is 
complex, involving direct actions of the renin-angiotensin system. 
Angiotensin II increases DNA synthesis of many cell types in vivo. 
Angiotensin II directly regulates DNA synthesis in the adrenal cortex 
and in blood vessels. Some of the effects of All are compensatory. 
Many of the effects of All on growth are influenced by blood pressure 
and by interactions with other factors such as nitric oxide and 
glucocorticoid hormones.
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Chapter 1 General Introduction
1.1. Endocrine Control of Cell Growth:
Functional changes in tissues influence their structure. 
Alterations within cells or in the extracellular matrix may be associated 
with the differentiation and development, maintenance, physiological 
adaptation, tumorigenesis or death of tissues. A complex series of 
signals leads to either a net increase in tissue mass by cell growth (with 
or without cell proliferation) or a reduction by atrophy and programmed 
cell death (apoptosis). This thesis will be concerned with changes in cell 
growth during adaptation to various physiological states in which the 
activity of the renin-angiotensin system and the cardiovascular system 
are altered.
The three main tissues responsible for the control of fluid and 
electrolyte homeostasis and blood pressure are the adrenal glands, the 
kidneys and the blood vessels. These tissues are under the control of 
endocrine and nervous systems which regulate their function: the 
secretory activity of the adrenal gland, the excretory role of the kidney 
and the vasoconstriction and vasodilation of blood vessels. In addition, 
these systems have trophic actions which regulate cell growth. Most 
tissues consist of a heterogeneous population of cells which are 
differentially regulated according to the imposed homeostatic demands. 
This means that the mass of a tissue can increase in response to an 
increased physiological demand or, conversely, if the demand is 
reduced and the stimulus for growth is removed, the tissue mass 
decreases.
Although tissues respond to longterm physiological stimulation, 
cell proliferation is also required to sustain a normal population of cells 
within each tissue. The rate of cell turnover varies: epithelial cells divide 
at a slower rate than parenchymal cells which, in turn, proliferate slower 
than smooth muscle cells. Cells which proliferate rapidly are often those 
which are susceptible to damage, such as the epithelial lining of the gut 
(1), or are also subject to increased apoptosis (1, 2) so as to maintain 
tissue mass. The mechanisms by which the mass of a tissue may be 
increased are cell proliferation in which mitosis and cell division takes 
place, and cell hypertrophy. Both may occur synchronously.
1.2. Endocrine Interactions:
The adrenal gland, kidney and blood \ csscls inlcracl lo regulate 
electrolyte and Huid balance and to control b lœ d  pressure and How 
(Fig. 1.1).
B lood p re s su re
N a+reabsorp Vasoconstricllon
Renin - Angiotensin 
System
Sympattielic nervous system
Catectiotam ines
G ucocorticoids
Mineralocoriicoids
l'ii; 1.1. The inUraction.\ q f  the mtr emit gtand, tiiciney and tAood vessels in regulating 
idood pressure and etecirotyle l?alance.
These interactions in\ o l\c  the control of hormones secreted b\ 
the adrenal cortex (mincrakx'orticoids and glucocorticoids).Thcse target 
the kidney and the cardiox ascular system w hich respond appropriately to 
influence this balance. Independent ol the adrenal, the kidnc) is 
scnsiti\ c to changes in blood pressure and scxlium concentration which, 
in turn, h a \c  a reciprocal cITcct on the rcacti\ ity ol blood \ csscls. The 
rcnin-angiotcnsin-aldostcronc system is central to the control ol the 
interactions between these tissues. Recently, it has been shown that 
humoral components ol this system also ha\ e growth-promoting actions 
(3).
1.3. Physiology of the Renin-Angiotensin-Aldosterone
System;
The principal ac li\c  component of the renin-angiotensin system 
is the cK'tapeptide angiotensin II (A ll). This is deri\ed  by a cascade ol 
e\ ents (Fig. 1.2) invoh ing firsth  the clea\ age ol angiotensinogen (renin 
substrate) b \ the asparty! proteinase renin to produce the decapeplide 
angiotensin 1. Angiotensin I is subsequently converted to A ll by the 
dipeptidase angiotensin con\ erting en/ym e (ACE).
Liver & other tissues
Angiotensinogen
Renin JGA of kidney
Angiotensin 1
Lung and other tissuesACE
Angiotensin II
Inactive peptide fragmentsTissue Angiotensinases
Angiotensin
1.2. The renin - an,f’iorcnsin cascade.
Angiotensin II acts in several \ \a \s  to increase sodium retention 
and blood pressure by i) stimulating the synthesis o f the potent 
antinatriureic hormone aldosterone in the adrenal cortex ii) through direct 
renal actions iii) as a direct \ asoconstrictor of arterial resistance \ essels.
The mechanism of the renin-angiotensin system in the control of 
the volume and composition of the extracellular lluid is complex and is
closch' related lo blood pressure regulation. Changes in actix il\ ol the 
renin-angiotensin system allow significant variations in sodium intake 
with only minimal changes in arterial pressure and extracellular lluid 
N olume (4). Ele\ ated blood pressure causes natriuresis and diuresis. As 
long as excretion exceeds intake, extracellular lluid \ olume continues to 
decrease, lowering \cnous return and cardiac output until pressure 
returns to normal and fluid intake and output is balanced (Fig. 1.3).
Juxta - 
Glomerular 
Apparatus
T Blood pressure 
(Na+)
Hypothalamus
/pituitary
Blood volume, 
p ressu re  & electrolytic 
balance resto red
Renin
AVPth ir s t
Na+ & 
w a te r  
uptake
Angiotensin II
v asoconstric tion
Adrenal zona 
glomerulosa Kidneyaldosterone
hi g 1.3. The role o f  the renin-angiotensin-aldosterone system in the 
regulation o f blood pressure and electrolyte balance.
In the kidney, the macula densa of the juxtaglom erular apparatus 
(JGA) responds to changes in distal tubular scxlium/chloride 
concentration and is, in part, responsible for this feedback kx)p (Fig 
1.3). U nder conditions o f low sodium or low blood \o lu m e, renin 
secretion is stimulated within juxtaglom erular (JG) cells o f the kidney. 
Angiotensin II generated from the rise in renin increases aldosterone 
secretion in the adrenal cortex. Bkxid-bome aldosterone acts on the
distal coiwolulcd and collecting tubules ol the kidne\ to promote 
reabsorption ol stxiium from the glomerular filtrate. The net inllux of 
sodium leads to an osmotic inllux of water from the filtrate and restores 
electrolyte composition and bkx)d \ olume. Arterial baroreceptors 
respond to changes in pressure and How. Low blood pressure acti\ ates 
the sympathetic ner\ ous system w hich, in turn, directly increases renin 
secretion rate and catecholamine secretion from the adrenal medulla. 
These substances in turn, directly or indirectly, promote 
\asoconstriction.
All stimulates the release of catecholamines from the adrenal 
medulla and peripheral sympathetic ner\ e endings and acts on the central 
nenoLis system to increase sympathetic nervous system acti\ ity (5, 6, 
7). Other actions on the central ner\ous system include (Fig. 1.4) the 
stimulation o f thirst, salt appetite and \ asopressin secretion (7).
ANGK)mNS#NM
, -------  LIVER
ADRENAL
VASCULAR BEDS
Glycogenolysis
G luconeogenesis
Stimulate Aldosterone 
release
Vasoconstriction
Increases 
plasm a glucose
Enhances distal nephon 
reabsorption
Increases arterial 
pressure
HEART Increases force of contraction
KIDNEY
INTESTINE
Direct vascular & 
transport effects
Reduces renal blood flo\w 
increases fractional sodium reabsorption
Stimulates salt & water 
reabsorption
  CNS
Stimulates thirst, salt appetite, ADH release 
increases sympathetic discharge, 
neurotransmitters
PERIPHERAL NERVOUS SYSTEM Facilitates adrenergic transmission
Fig 1.4. Multiple physiological effects of angiotensin II.
All also increases hepatic gluconeogenesis and glycogenolysis 
(8, 9) and stim ulates salt and water absorption by all segments of the 
intestine ( 10). In general, the physiological effects of All act together to
promote the consenaiion of salt and water and the maintenance of 
extracellular fluid volume and arterial blood pressure.
1.3.1. Renin and the Juxtaglomerular Apparatus:
Renin is synthesised as a large inactive precursor, preprorenin 
(Mwt 45 Kd), that is concerted first to a smaller inacti\e form, prorenin 
(Mw i 42 Kd) and then to active renin (Mwt 35-40 Kd) (11). In plasma, 
renin circulates in both active and inactive forms (12, 13). Both forms 
are synthesised and stored in granules w ithin the JG cells of the renal 
arterioles. JG cells constitute part of the JGA which is sensiti\e to 
plasma sodium concentration and is involved in the control of systemic 
blood pressure (refer to Fig. 1.5).
F ig .] .5. The Juxtaglomerular Apparatus
The JGA has three components: JG cells (14), macula densa 
cells (15) and lacis or Goormaghtigh cells (16) which comprise the 
extraglomerular mesangium. JG cells, derived from the smooth muscle 
of the wall of the glomerular arteriole, form a cuff around the vessels 
just before they enter or leave the glomerulus. They ha\e prominent 
nuclei and cytoplasm with renin-containing granules (17, 18). The 
macula densa consists of modified distal convoluted tubular (DCT) cells 
and is found where the JG cells and DCT are closely apposed. These 
cells are columnar and ha\ e larger more prominent nuclei than other cells 
of the DCT. The extraglomerular mesangium is a small group of cells 
which lies betw een the macula densa and Bow man's capsule at the point 
of entry of the afferent arteriole. A dense assembly of adrenergic 
terminal nene axons is also found in the JGA where smooth muscle
cells and granular cells arc large I sites for catecholamines; a sympathetic 
stimulus causes renin release from granular cells ( 19).
1.3.2. Regulation o f  Renin Secretion:
Changes in renal perfusion pressure directly alter renin secretion 
(19) and it is postulated that the JG cells, or associated endothelial cells, 
act as barorcceptors such that changes in the stretch or tension of the 
afferent arteriolar wall due to alterations in renal perfusion pressure elicit 
reciprocal changes in renin secretion rate (refer to Fig. 1.6).
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Fig 1.6. Fhysiological mcvhcmisms regulating renin 
secretion.
The cytosolic concentration of ioni/ed calcium is an important 
intracellular signal which regulates the release of enzymes and 
hormones; the secretion of renin is stimulated by reductions rather than 
increases in cytosolic calcium lexels (19). Increased stretch of the 
afferent arteriole depolarizes the JG cells resulting in increased calcium 
entiy and cle \a ted  cyto.solic calcium le\ els. Subsequently, this leads to a 
reduction in renin secretion rate (19). Decreased stretch results in
hyperpolarization of the JG cells which leads to decreased calcium influx 
and stimulation of renin secretion.
Reduced sodium chloride at the macula densa is associated with 
enhanced renin secretion (20) indicating that renin secretion rate is 
inversely proportional to the sodium chloride load to the macula densa. 
Skott and Briggs (21) demonstrated that a decrease in the sodium 
chloride concentration of the tubular fluid at the macula densa increases 
renin secretion rate. The mechanism by which this interaction occurs is 
uncertain but may be due to a suppressive influence of signals from the 
macula densa cells. Itoh et al (22) demonstrated that isolated afferent 
arterioles with a macula densa segment attached exhibited lower renin 
secretory rates than arterioles without the macula densa. Although the 
signal remains unknown, adenosine released from the macula densa 
cells may act directly on the adjacent JG cells to inhibit renin secretion 
(22).
The renal nerves and circulating catecholamines also influence 
renin secretion. JG cells are innervated by adrenergic nerve terminals 
(23). Low-level renal nerve simulation increases renin secretion through 
activation of fl-adrenoreceptors on the juxtaglomerular cells (19, 20, 23, 
24) whereas direct activation of a-adrenoreceptors by norarenaline 
inhibits renin secretion. However, activation of a~adrenoreceptors and 
renal nerve stimulation at higher intensities indirectly stimulate renin 
secretion via activation of the macula densa and baroreceptor 
mechanisms. With the exception of noradrenaline, circulating 
catecholamines released from the adrenal medulla stimulate renin 
secretion through activation of B-adrenoreceptors.
All and vasopressin act directly on the JG cells to inhibit renin 
secretion (19, 20, 25). The inhibitory effects of these hormones are 
dependent on the presence of extracellular calcium indicating that both 
All and vasopressin (AVP) inhibit renin secretion by enhancing calcium 
influx into the juxtaglomerular cells (19). In vivo. All inhibits renin 
secretion by negative feedback mechanisms. In vitro, inhibition of renin 
secretion by All is well documented (3).
Recent studies have demonstrated direct inhibition of renin 
secretion by the vasodilator nitric oxide (26). The mechanism of control 
is not entirely understood but it is thought that renin gene expression is 
inhibited via activation of cyclic-GMP. Adenosine also inhibits renin 
release by a direct effect on the secretory cell (27) and by attenuation of 
B-adrenoreceptor stimulation (28).
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1.3.3. Angiotensinogen:
Angiotensinogen, otherwise known as renin substrate, is
synthesised and secreted predominantly in the liver (29) but has also 
been detected in renal lymph (30) and in granules of the proximal tubule 
cells (31). Angiotensinogen mRNA is present in the cortex and medulla 
of rat and mouse kidneys (11, 32, 33) although much of this has been 
localised to proximal tubule cells of the cortex (34). The availability of 
renin substrate is a prerequisite though not normally a rate-limiting step 
for All production.
1.3.4. Angiotensin Converting Enzyme:
The main site of conversion of circulating angiotensin I to 
angiotensin II is the surface of vascular endothelial cells in the lung 
which are rich in converting enzyme (ACE) (35). ACE has also been 
found in endothelial cells of the testes, brain, liver adrenal cortex, 
pancreas, spleen and kidney (36) and it is present on vascular 
endothelial cells of all kidney arteries, the afferent and efferent arterioles, 
some glomerular and peritubular capillaries and on the brush border and 
basolateral membranes of the proximal tubule cells (30, 37). The 
presence of ACE within such a diversity of tissues is compatible with 
the existence of local renin-angiotensin systems.
1.3.5. Angiotensin II:
All circulates in plasma at low concentrations and has a very 
short half-life (38). Within the kidney. All levels are controlled in 
several ways (Fig. 1.7). Firstly, local renin will convert blood borne 
renin substrate to angiotensin I which in turn will be converted to All by 
ACE located on the luminal surface of the vascular endothelial cells. All 
can also be generated intrarenally as a result of renin secretion into the 
interstitium. Renin in the interstitium (39) finds its way into renal lymph 
(30,40). Angiotensin I formed in the interstitium is probably converted 
to All by ACE in the interstitial fluid or bound to basolateral membranes 
of the proximal tubule cells. All has also been identified in JG cells and 
although uptake from the extracellular compartment is possible. All may 
also be formed intracellularly since both renin and angiotensins have 
been demonstrated immunocytochemically within secretory granules 
(17, 18, 40, 41). It follows that All, whether or not it is generated 
within juxtaglomerular cells, is probably released together with renin.
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Fif^  1.7. The various means by which anf-ioien.sin //  may be generated intrarenally.
1.3 .6 . Physiological Effects o f Angiolcnsin II on the Kidney:
Inlrarcnal A ll directly regulates renal excretion of electrolytes 
and ater at several le\ els (42). There is a high densit) of A ll receptors 
on renal glomeruli (43, 44) and contractile effects of All on isolated 
glomeruli and cultured smooth mucle cells are well established (45). A ll 
inlluences glomerular filtration rate and renal b lœ d  How by direct 
\asoconstriclion o f pre- and post-glomerular resistance \esse ls  (46). 
Mesangial cells contain smcxith muscle actin and contract in response to 
stimulation with A ll (47, 48). Mesangial cell contraction reduces 
glomerular capillarx volume and filtration surface area thereby reducing 
ultrafiltration. In the proximal tubules. All directly stimulates sodium 
and fluid resorption (49). Indirectly, All promotes antinatriuresis in the 
distal nephron by stimulation of biosynthesis and secretion of 
aldosterone in the adrenal /.ona glomerulosa (see later). There is also 
e\ idence that A ll modulates countercurrent and concentrating 
mechanisms within the nephron by controlling renal medullary bkx)d 
How (50).
Man) haem od\ namic actions of All are effected b \ blood borne 
A ll. H ow e\er, all the components necessary for the intrarenal 
generation of All are present within the kidney indicating that a 
substantial amount of A ll may be generated lœ ally  w hich, in turn, may 
ha \e  paracrine or au tœ rine  functions (49). This is supported b\ higher 
renal tissue All than intrarenal plasma concentrations (51, 52, 53).
10
Intrarenal levels of All are increased by sodium deprivation or 
converting enzyme blockade (52).
Renal Growth Effects:
In addition to its many other physiological actions, the autocrine 
or paracrine effects of All may also mediate changes in cell growth (54). 
Many growth factors are multifunctional regulators, their biological 
effects being dependent on the target cell type and on the presence of 
other factors in the local milieu. All has many of the characteristics of 
the 'classical' growth factors: it binds to specific cell surface receptors 
(55); activates a number of intracellular signalling pathways associated 
with cell growth (56) and induces proliferation of a variety of cells (57, 
58). Furthermore, the fact that many renal cell types respond to All in 
vitro, and possess All receptors (43,44, 59) imply a role for All in the 
regulation of renal cell growth.
1.3.7, Extrarenal Renin Angiotensin Systems:
There is much evidence for extrarenal renin-angiotensin systems. 
Large amoimts of tissue renin and renin isoenzymes have been found in 
many tissues including brain, adrenal gland, lung, large arteries and 
veins, uterus, placenta and the submandibular gland of the mouse (5). 
Renin has been detected in the adrenal gland following nephrectomy 
(60) and has been localised to specific intracellular sites within the 
adrenal cortex. Renin messenger RNA and other components of the 
system have been detected in brain, heart, adrenal gland and testis in 
both the mouse and the rat and also in the submandibular gland of the 
mouse (11, 61). Angiotensinogen (renin substrate) has been detected in 
the arterial wall (62) suggesting that a local renin-angiotensin system 
within the vasculature may have paracrine or autocrine effects.
1 . 4 , 1 .  Structure and Function of the Rat Adrenal Gland:
The mammalian adrenal glands are encapsulated paired organs 
which lie superior to the kidneys. The cortex and medulla are 
histologically and embryologically distinct. The adrenal cortex is divided 
into four concentric zones: (refer to Fig. 1.8).
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Fig.J.8. The Zones o f  the AJult Rat Adrenal Cortex. ZG (Zona Glomernlosa), ZI 
(Zona hitermedia), ZF (Zona Fasciculata), ZR (Zona Reticularisj
i) Ztma Glomerulosa:
The zona glomerulosa lies just below the connective tissue 
capsule and consists of layers of subcapsular aggregates of irregularly 
arranged parenchymal cells which occupy approximately 10-15% of 
the gland volume. The cells are ovoid or round with cytoplasm 
containing abundant lipid (63). These cells produce the major 
mineralocorticoid, aldosterone. (Fig. 1.9). The synthetic pathway for 
aldosterone starts from cholesterol and involves a series of 
dehydrogenation and hydroxylation reactions. The uptake of 
cholesterol into mitochondria and subsequent conversion to 
pregnenolone by the enzyme cytochrome-P450 is the first and one of 
the rate-limiting steps for aldosterone synthesis; the subsequent 
conversion of deoxycorticosterone to aldosterone is also closely 
regulated.
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Aldosterone acts to conserve sodium at sc \cral sites (sweat 
glands, colon, salixary glands, kidney). In the k id n c \, the hormone 
stimulates scxlium rcabsorption from the distal tubule and collecting duct 
segments ol the nephron (64) b\ tw o mechanisms: firsth  b\ acti\ ation 
ol either luminal membrane sodium channels (64) which increases 
intracellular sodium concentration, or sccondh by acti\ation ol stxiium 
channels \ ia a reduction in the intracellular calcium concentration (65). 
1 ncrcascd am ounts ol sodium ions are exchanged for potassium or 
hydrogen ions leading to decreased scxlium excretion (anti natri uresis) 
and increased potassium (kaliuresis) and Indrogen ion excretion.
In the rat, aldosterone secretion is controlled largely by All (66) 
although other factors such as plasma potassium (K*^) concentration 
(67) and adrenocorticotrophic honnone (ACTH) (68) are also in \'oh  ed. 
Signal-response coupling mechanisms for A ll, ACTH and potassium 
are com pared in Fig. 1.10. All three agonists depend on extracellular 
C a-+ . All and K"*" both raise intacellular Ca-"*'; ACTH acts mainly 
through cyclic-AM P (69). The zona glomerulosa cell is particularly 
sensitive to the depolarising effects of raised extracellular K ’^  which 
causes calcium uptake through voltage sensitive channels. All binds to 
receptors which activate phospholipa.se C, triggenng stored calcium 
release via inositol 1-4-5 trisphosphate as well as opening plasma 
membrane calcium channels. Arginine vasopressin (70), serotonin (71) 
and vasoactive intestinal polypeptide (72) also stimulate aldosterone 
secretion but are physiologically less important. Atrial natnuretic peptide 
(73), dopam ine (74), and somatostatin (75, 76) inhibit release.
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In vivo, dietary sodium intake is the major determinant of 
aldosterone secretion. Dietary sodium restriction enhances aldosterone 
secretion through raised plasma All levels (77), up-regulation of All 
receptors on glomerulosa cells (78) and removal of the tonic inhibitory 
influence of dopamine (74). In addition, there is evidence of a local 
renin-angiotensin system which is more active after adaptation to a low 
sodium diet (60). However, the contribution that this paracrine system 
makes to the net output of aldosterone is uncertain.
ii) Zona Intermedia:
The zona intermedia is not identifiable in all species. In the rat, it 
lies immediately below the zona glomerulosa and consists of two or 
three layers of small cells containing regularly ovoid nuclei and scanty 
cytoplasm. These cells contain little or no lipid droplets (63) and it has 
been postulated that they are transitional cells between the zona 
glomerulosa and zona fasciculata (63). The zona intermedia has also
,been described as the amitotic zone of the adrenal gland (79, 80). Others 
claim that zona glomerulosa and zona fasciculata cells originate here 
(81).
a:
iii) Zona Fasciculata/Reticularis:
The major part of the cortex (50-60%) comprises the zona 
fasciculata. It contains large, clear, lipid-containing cells centripetally 
arranged in narrow columns or cords between the zona intermedia and 
the zona reticularis. These secretory cords are normally one cell thick 
and are separated and supported by connective tissue strands containing 
capillary sinusoids. The plasma membrane of the secretory cells lies 
subjacent to the endothelium of the capillary sinusoids. The cytoplasm 
of the fasciculata cell is packed with mitochondria containing 
tubulovesicular cristae. In the zona reticularis the secretory cords 
become less clearly organised and appear as an irregular network of 
branching cords and clumps of eosinophilic glandular cells separated by 
numerous wide capillary sinusoids. The glandular cells are much smaller 
than those of the other zones, the cytoplasm contains few lipid droplets, 
abundant lipofuscin and the mitochondria are more sparse than in the 
fasciculata.
The zona fasciculata and zona reticularis are thought to act as a 
functional unit in the production of glucocorticoids, such as cortisol 
(human) and corticosterone (rat), and androgens (refer to Fig. 1.9).
:'À:
Glucocorticoid secretion by the zona fasciculata is controlled almost 
exclusively by the activity of the hypothalamo-pituitary axis and the 
release of ACTH. The actions of ACTH are mediated by binding to cell 
surface receptors. The receptor is linked to a plasma membrane 
adenylate cyclase, and causes an increase in intracellular cyclic-AMP by 
stimulating adenylate cyclase activity. This, in turn, promotes 
steroidogenesis. As with aldosterone, the major control point in the 
pathway is the cleavage of cholesterol to pregnenolone.
Glucocorticoids promote glycogen and protein synthesis in the 
liver but are catabolic in most other tissues, increasing lipolysis and 
protein breakdown and reducing glucose uptake from the circulation. 
Glucocorticoid receptors are also expressed by most cell types in the 
kidney. They promote natri uresis by raising glomerular filtration rate, 
and modulating Na+-H+ exchange in the proximal tubule (82). 
Glucocorticoids increase renal plasma flow as a result of increased 
afferent and efferent arteriolar resistance possibly due to increased 
contractility of vascular smooth muscle cells (83).
1.4.2. Cytogenesis of the Adrenal Cortex:
During normal adult life, following postnatal growth and 
development, a constant supply of differentiated new cells is required to 
sustain a normal functional cortical parenchyma (84). Two theories have 
been proposed to explain adrenocortical cytogenesis. The 'migration 
theory', originally proposed by Gottschau (85), is based on the 
interdependence of the cortical zones with respect to their cellular origins 
and their fate after differentiation. It proposes that cell proliferation 
occurs mainly at the periphery of the cortex to displace existing cells 
centripetally. New cells differentiate into zona glomerulosa cells and, as 
they are displaced inwards they change into fasciculata cells and, finally, 
as they reach the inner cortex, they become reticularis cells before being 
eliminated. This theory is backed by experimental evidence: most of the 
cell proliferative activity appears to occur at the periphery of the cortex in 
both the immature (86) and the adult rat (87) and there are few mitoses 
in the inner zones (88, 89). In the reticularis, there are abundant 
pyknotic nuclei, lipofuscin inclusions and mitochondrial degeneration 
which are all indicative of cell senescence and death. Apoptosis is 
common in the reticularis (2, 90). Furthermore, the migration of cells 
from the outer to the inner zones has been demonstrated by nuclear pulse 
labelling experiments. DMA labelling with tritiated thymidine in foetal
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and neonatal (91), prepubertal (92, 93) and adult animals (93, 94) has 
shown that cells originally labelled at the glomerulosa or outer 
fasciculata boundary are sequentially displaced to the inner zones of the 
cortex, before disappearing.
The alternative 'zonal theory' of adrenocortical cytogenesis was 
proposed first by Swann (95) and supported later by Race & Green 
(96). It states that the zones of the adrenal cortex independently increase 
or reduce mass in response to physiological demand. Each is therefore 
self-sustaining. The argument for a zonal theory is based on the 
histological and functional heterogeneity of the cell types.
The three zones of the cortex produce different steroid hormones 
and are, in part, differentially regulated. The zonal theory is supported 
by evidence that external stimuli selectively promote changes in cell 
growth within the different zones of the cortex. The zona glomerulosa is 
relatively independent of ACTH (97); hypophysectomy leads to 
profound atrophy of the cortex which is more marked in the inner zones 
(98) than in the zona glomerulosa although the secretory rate of the zona 
glomerulosa is affected by removal of ACTH (99). Indeed, ACTH 
promotes cell hypertrophy of the fasciculata and to some extent the 
reticularis in response to increased demand for glucocorticoids or I
androgens (98). The hypertrophic actions of ACTH on the reticularis are 
enhanced in the presence of prolactin during gonadectomy (100) and 
there is evidence of mitotic activity in the zona reticularis (96, 101).
Although pituitary control of adrenal growth has focussed largely on the 
effects of ACTH, Estivarez et al (1982) (102) have demonstrated that 
pro-opiomelanocortin (POMC), a peptide from which ACTH is derived, 
is a potent independent mitogen in the adrenal cortex following 
adrenalectomy or adrenal damage. Whether POMC influences the 
differentiation of the cortex during regeneration is not clear.
Chronic treatment with corticosteroids leads to atrophy of the 
fasciculata and reticularis (103) mediated either directly (103) or 
indirectly via suppression of ACTH (104). The steroidogenic demands 
on the zona glomerulosa are reflected by changes in growth; All raised 
by dietary sodium restriction leads to an increase in width of the zone 
(105). Moreover, the zona glomerulosa may be reduced by inhibitors 
such as atrial natriuretic peptide (106), dopamine (74) or captopril, an 
angiotensin converting enzyme inhibitor (107).
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1.4.3. The Adrenal Medulla :
The adrenal medulla is composed of closely packed clumps of 
secretory chromaffin cells or pheochromocytes supported by a fine 
reticular network containing numerous wide capillaries. Sustentacular 
cells are interspersed between the nests of pheochromocytes. Scattered 
groups of ganglion cells are also present.
The chromaffin cells of the adrenal medulla secrete adrenaline, 
dopamine and noradrenaline under the control of preganglionic neurones 
of the sympathetic nervous system. Catecholamines produce a variety of 
haemodynamic and metabolic effects by binding to either a  or B 
receptors. The haemodynamic effects include an increase in the rate and 
force of myocardial contraction (Bl), vasoconstriction (a l) ,  and 
vasodilation (B2). Noradrenaline produces generalised vasoconstriction 
and an increase in both systolic and diastolic blood pressures. 
Adrenaline produces vasoconstriction in many vascular beds and 
increases cardiac output and heart rate but also causes vasodilation in 
tissues populated with B2 ad renoreceptors including skeletal muscle. 
Dopamine increases cardiac output, reduces mesenteric and renal 
vascular resistance while producing vasoconstriction elsewhere. Other 
effects of catecholamines include stimulating renin secretion (24) and 
oveniding vasorelaxatory effects of nitric oxide (108).
Chromaffin cell growth is not well documented but is thought to 
be mediated largely through the action of nerves (109). Low blood 
pressure results in increased DNA synthesis in rats (110). The 
circulating catecholamines produced by the adrenal medulla are growth 
factors for some tissues (111, 112) but whether they act in a paracrine 
or autocrine fashion is not known.
1.5.1. Structure and Function of Blood Vessels.
In vertebrates the blood vessels and the heart constitute a closed 
vascular system. A blood vessel consists of three cell types: endothelial 
cells, smooth muscle cells and connective tissue cells embedded in 
nerves. They are organised in three distinct stixictures, the intima, media 
and adventitia respectively. The vascular tree is a circuit that conducts 
blood from the heart through large diameter, low resistance vessels to 
small arteiies and arterioles. The capillaries are thin-walled and allow the 
exchange of nutrients and waste products between tissue and blood, a 
process that requires a large surface area. The circuit back to the heart is 
completed by the veins which are distensible and provide a volume
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buffer that acts as a capacitance for the vascular circuit. The physical 
factors which determine intravascular pressure are cardiac output (a 
product of stroke volume and heart rate) and total peripheral resistance 
(narrowness of small arteries and arterioles). The relative contribution 
that cardiac output and total peripheral resistance make to blood pressure 
varies. For example, in the Goldblatt two-kidney one clip model of 
hypertension, cardiac output is initially increased in the presence of 
normal total peripheral resistance. Later, output falls but resistance 
increases to maintain high blood pressure. With time, cardiac output 
falls further and total peripheral resistance increases even more, leading 
to a sustained form of hypertension. The mechanism for progressive 
increased peripheral vascular resistance is attributed to thickening of the 
media of blood vessels with narrowing of the lumen (113).
1.5.2. Definition of Vascular Hypertrophy:
Vascular hypertrophy is defined as an increase in mass of any of 
the histological layers of blood vessels. In hypertension, the earliest 
changes have been observed in the media of small arteries and arterioles, 
whereas in other disease states such as arteriosclerosis there is 
proliferation of the intima (114). Unlike man, the intima of the rat is less 
well developed and consists only of a single layer of endothelial cells. 
Therefore, for the purpose of this study, hypertrophy of blood vessels 
will refer only to thickening of the media.
The process of arterial thickening may be regarded as a 
necessary adaptation to prevent damage to the microcirculation and to 
prevent over-perfusion of tissues. This lead Folkow (115) to propose 
his theory of vascular amplification in which small increases in blood 
pressure cause an increase in vascular smooth muscle cell mass in 
resistance vessels which in turn increase blood pressure (Fig. 1.1 la). 
This results in hypertrophied blood vessels which are characterised by 
an increase in the lumen/wall ratio. More recently, others have suggested 
modifications of this theory involving the direct actions of smooth 
muscle mitogens (refer to Fig. 1.1 lb) (111).
19
A
m echanism  ‘ BP f  ^  hypertrophy
L H a
BP t  hypertrophy ^ m echanism
L l l b
f ig s  1.11a  A  1.1 lb . Tbe amplificaiion o f  blood pressure by hypertrophy and the 
possible role o f  growth factors.
Three mechanisms ha\c been proposed to explain \ascular 
hypertrophy: hyperplasia, cellular hypertrophy and remodelling (refer to 
Fig. 1.12). Hyperplasia is an increased number of smooth muscle cells, 
whereas cellular hypertrophy is an increase in size of the existing 
smooth muscle cells as a result of increased protein synthesis (116) or 
polyploidy (117). Remodelling refers to an increased lumen/wall ratio 
due to a rearrangement of the existing cells around a smaller lumen (118, 
119). These phenomena vary in different parts of the circulation. For 
example, hypertrophy of smooth muscle cells of large conductance 
arteries such as the aorta is associated with polyploidy (120), whereas 
mesenteric resisttmce vessels are either remodelled (121, 122) or 
thickened by hyperplasia (123, 58).
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1.5.3. Ejfects o f  Angiotensin II on Blood Pressure and  Vascular
Growth:
All directly stimulates vascular smooth muscle cell contraction 
increasing blood pressure acutely by vasoconstriction (55). The 
excitation-contraction coupling mechanism involves a depolarisation of 
the cell membrane after binding by All to specific smooth muscle cell 
receptors. Depolarisation activates voltage-dependent Ca^+ channels 
leading to an influx of Ca^+. The intracellular free Ca^+ concentration 
regulates vascular contraction by binding to calmodulin which then 
associates with myosin light chain kinase, initiating contraction.
When infused in animals at a dose below the threshold of its 
acute vasoconstrictor effect. All raises blood pressure slowly and 
progressively (124, 125). Although the mechanism for this slow action 
is uncertain, it has been postulated that vascular hypertrophy develops 
during the slow response, and that All may be an important growth 
factor in vivo  (126). Furthermore, in young normotensive Wistar-Kyoto 
rats, hypertrophy of the arterial media appears to be related specifically 
to growth effects of All rather than indirect effects of pressure or growth 
effects of catecholamines (127). The hypothesis that All acts as a 
growth factor has also been strengthened by studies using ACE 
inhibitors and All receptor antagonists (128, 129) which demonstrate 
either prevention or regression of hypertrophy. Tested in vitro. All 
either stimulates cell proliferation (130, 131) or increases cell size 
without cell division (132) depending on the type of blood vessel 
studied.
1.5.4. O ther Factors which Control B lood Vessel Growth:
Other vascular derived growth factors also contribute to the 
normal and pathological growth of blood vessels (133). Platelet-derived 
growth factor, transforming growth factor beta, insulin-like growth 
factor and fibroblast growth factor regulate smooth muscle cell growth 
in vitro and in vivo  and are thought to elicit paracrine or autocrine effects 
on growth (133, 134). They are known to act both independently and 
synergistically with All ( 135) and in vitro are dependent on the presence 
of insulin in the growth medium (3).
Cellular and M olecular Mechanisms:
The cellular and molecular mechanisms of growth of smooth 
muscle cells are poorly understood and are difficult to study because cell 
growth requires a multitude of factors which bind to or activate cells in a
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finite or temporal sequence (136). The progression of cells from the 
interphase of the cell cycle to the mitotic phase is not an all or none event
■but involves programmed activation of a series of genes. If the 
conditions fail to meet the demands of the cell, growth can be arrested 
following DNA synthesis (polyploidy) without proceeding to the mitotic
phase of the cell cycle. Alternatively, the cell may be eliminated by
.apoptosis.
Calcium plays an important role in these processes (136); in 
many cells there is a positive relationship between the cytosolic free 
calcium concentration ([Ca^+]) and mitogenesis. Contractile effects of 
All occur together with the mobilization of Ca^+ either by uptake via the 
cell membrane or by release from intracellular stores (55); this 
relationship may contribute to the trophic action of All in vascular 
smooth muscle cells (116). Vascular smooth muscle cell membranes 
defective in Ca^+ handling may increase intracellular free calcium levels 
and increase peripheral vascular resistance, thereby enhancing the 
vascular amplifier. Mechanisms are either decreased membrane-bound 
[Ca2+] leading to a decrease in membrane potential, depolarisation and 
hyperexcitability ( 137) or reduced Ca^+ efflux by failure of the Ca^+
ATPase pump ( 138)
All and many other mitogens increase Na+/H+ exchange in 
vascular smooth muscle cells (139); leading to intracellular alkalinisation 
which is widely considered to be a trigger for growth (140). Enhanced 
Na+ permeability also increases intracellular calcium concentrations and 
promotes vascular tone.
Mechanical Factors:
Blood pressure or wall stress mediates smooth muscle cell 
hypertrophy in hypertensive animal models (120). Stretching cultured 
aortic smooth muscle cells increased protein, collagen and elastin 
synthesis (141). In addition, stretching vascular smooth muscle cells 
promotes the expression of the proto-oncogene c-fos (142). Expression 
of c-fos, c-myc and c-jun are also inducible by All (142,143, 144,265) 
raising the possibility that the growth effects of All and stretch are 
mediated by the protein products of these genes.
Endothelial Factors:
The endothelium influences growth of arterial smooth muscle 
(114). Removal of the endothelium in vivo induces proliferation and 
migration of smooth muscle cells (114, 145). In vitro, isolated 
endothelial cells produce factors that either inhibit or promote the
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proliferation of arterial smooth muscle cells. Endothelium derived 
relaxing factor and prostaglandin E2 are two of many vasoactive agents 
derived from the endothelium which inhibit proliferation of vascular 
smooth muscle cells (146).
Extracellular Matrix:
In hypertension, the extracellular matrix expands by an increase 
in collagen, elastin and glycosaminoglycans (147). Additional matrix 
contributes to resistance by stiffening the vessel, reducing compliance 
and increasing resistance (148).
1.6. M ethodology:
Hypertrophy of tissues may be determined by various 
techniques. Changes in weight reflect an increase in number of the 
components of the tissue and/or the size of its cells. Gross histological 
changes may be observed by light microscopy aided by the use of 
special stains or measured with the use of an eyepiece graticule with a 
Vernier scale or grid (149). More rapid measurements may require an 
automated computerised image analysis system for calculating area 
fractions. Pressure or wire myographs which determine force-internal 
circumference relationships (150) have been used to characterise 
hypertrophy of blood vessels. However, the size of blood vessel 
selected is restricted to those with a lumen large enough to accommodate 
pieces of wire. Subtle changes in the size of cells or their organelles may 
be determined by electron microscopy.
Growth is often assessed by changes in DNA synthesis. Various 
techniques may be used to determine this. The simplest is the mitotic 
index which counts the number of mitoses in a tissue. However, since 
mitosis is a rapid transient event, large number of cells have to be 
counted to assess the degree of mitosis accurately. Colchicine has been 
used in cell replacement studies, however this technique involves 
arresting cells in mitosis and frequently yields conflicting results (151). 
The DNA content of cells may be measured by the use of special stains 
such as Feulgen which binds stoichoimetrically to DNA. These stains 
lend themselves to quantitative analysis by either 
microspectrophotometry, static image analysis or flow microfluorimetry 
and are based on the transmission and/or absorption of light. The light 
transmitted is related to the staining intensity which is directly 
proportional to the DNA content. These techniques are particularly 
useful for measuring pioidy and may be modified for the measurement
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of cellular protein content. Nuclear labelling experiments using 
analogues of pyrimidine such as tritiated thymidine ([^H]TdR, 
bromodeoxyuridine (BrdUrd) or iododeoxyuridine (IdU) may be used 
to determine the degree of DNA synthesis of a tissue by being 
incorporated into the DNA during the synthetic phase of the cell cycle 
(refer to Fig. 1.13).
Daughter 
cell
Daughter 
cel
D aughter 
nuclei
Nuc ear events
Growth phase
Cellular even ts
Fig 1.13. The eukaryotic cell cycle. Note that the synthetic (s) phase occurs 
during the interphase.
The labelled nuclei are detectable in single-stranded DNA by 
immunocytochemistry or fluorescence microscopy (152, 153). The 
BrdUrd technique is particularly useful in longterm studies as there is no 
requirement for expensive radioactive isotopes, the cells which 
incorporate BrdUrd are quickly and easily detected by 
immunocytochemistry (152), the coloured end-product is chemically 
stable and an index of DNA synthesis may be achieved by cell counting 
either manually or automatically using an image analysis system. This
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technique is superior to [^H]TdR where localisation is limited by the 
distance of travel of the emitted 6 particles, the grain size of the 
photographic emulsion, by the exposure time and by the limited 
resolution of autoradiographs. The application of this technique may 
also be extended to include the analysis of wax-embedded tissues after 
in vivo labelling of intact animals (154).
1.7. Image Analysis:
Most image analysis systems consist of a conventional 
microscope coupled to a video camera which acts as the image sensor. 
The camera produces a voltage signal proportional to the light intensity. 
The principal stages thereafter require five main steps: (i) image capture 
which involves the conversion of the image into an electronic signal 
suitable for digital processing; (ii) segmentation describes the act of 
separating the regions of interest within an image from the background 
by thresholding which means that all tones below a selected level are 
treated as black and all above as white. The end product becomes a 
binary image of the object expressed in pixels; (iii) object detection is 
used to signify each of the individual regions of interest (i.e. radius of 
the media of a whole blood vessel) and is the component of the image 
which is to be measured; (iv) measuring provides a quantitative value 
which is transferred from pixels into real 'units'; (v) analysis, once the 
measurements have been made the results can be analysed by computer 
and decisions can be made on how the measurements can be presented 
graphically.
1.7.1. Analysis o f  P ioidy Using Com puterised Im age Analysis:
Static image analysis cytometry has been developed for the 
assessment of pioidy providing the tissue architecture is maintained. 
This allows operator interaction in the process of cell selection (155). 
Image analysis is possible from tissue sections obtained from paraffin- 
embedded material and facilitates staining of DNA with Feulgen's stain. 
The Feulgen stain reacts stoichiometrically with DNA to allow the 
amount of staining to correlate directly with the DNA content of the 
nucleus. The reaction is based on the hydrolysis of deoxyribose-purine 
bonds in the DNA to produce reactive sugar aldehydes that can be 
demonstrated with Schiff's reagent. As light is passed through a 
feulgen-stained nucleus, a proportion of the light is absorbed and the 
remaining light is transmitted. The stoichiometric binding of the Feulgen
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stain allows for the transmitted light to be interpreted and related directly 
to the DNA content of the cell. With careful calibration the pixel 
information can be related to nuclear DNA content.
1,8. Aim of the Study:
The renin-angiotensin-aldosterone system plays an important 
role in the aetiology and pathogenesis of hypertension. One of the main, 
but less considered features in this development, is the role of DNA 
synthesis in the target tissues. Most experiments have been performed in 
vitro. In vivo experiments have involved short-term studies applied to a 
slow adaptive process (156). Few have attempted to study progressive 
changes in growth over a realistic period of time for tissues to adapt to 
manipulations of the renin-angiotensin system. The aim of this study is 
to investigate the effects of longterm modulation of the renin-angiotensin 
system on cell growth of the target tissues. The renin-angiotensin 
system will be manipulated in rats by dietary sodium depletion (raising 
renin and plasma All), infusions of a slow pressor dose of All (increase 
plasma All and lower plasma renin activity), and treatment with 
captopril to block the conversion of AI to All (raising plasma renin 
activity but lowering All). Bromodeoxyuridine will be infused 
continuously throughout and the effects of treatment on DNA synthesis 
will be assessed by immunocytochemistry in adrenal glands, kidneys 
and blood vessels. In addition, growth effects on blood vessels from all 
ordeis of the vascular tree will be measured morphometrically.
Some fonns of hypertension are renin and therefore All 
independent. Administration of deoxycorticosterone (DOC) salt by 
promoting sodium retention, increases blood pressure and has a negative 
feedback effect on renin secretion. Increased DNA synthesis in vascular 
smooth muscle cells in this instance is increased ( 157) without elevated 
systemic levels of All. It is postulated that blood pressure alone is a 
stimulus for DNA synthesis (117, 157, 158). The second aim of this 
study, therefore, is to assess whether increased activity of the renin- 
angiotensin system is a pre-requisite for growth. Hypertension induced 
by glucocorticoid excess does not appear to involve changes in systemic 
activity of the renin-angiotensin system. Therefore, the effects of the 
synthetic glucocorticoid, dexamethasone, on DNA synthesis will be 
assessed. Furthermore, corticosteroids also cause hypertension by a 
slow mechanism and it is suggested that amplification by hypertrophy 
occurs during the slow response (111) however, the effects of
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dexamethasone as a trophic factor in vivo in smooth muscle cells have 
not been studied.
Inhibition of nitric oxide synthase promotes local |
vasoconstriction and, in the longterm, hypertension (159). The f
mechanism of increased blood pressure may be direct or secondary to 
changes in the renin-angiotensin system. A direct mechanism is 4
indicated by evidence that renin is suppressed acutely by nitric oxide 
(26). The longterm effects of nitric oxide suggest a secondary, renin- 
dependent form of hypertension. However, there is little information 
regarding alterations in DNA synthesis in blood vessels and whether or 
not vascular hypertrophy is a main feature in the early stages of |
hypertension. The secondary effects of stimulating the renin-angiotensin 
system may also be reflected by changes in growth of the adrenal gland.
Furthermore, prolonged inhibition of nitric oxide synthase with L- 
arginine inhibitors results in malignant hypertension and renal necrosis 
(160), the early stages may reflect changes in renal cell growth.
‘■-d
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Chapter 2 Materials and Methods
2.1. Rats:
Male Sprague Dawley and Wistar rats were purchased from Harlan 
Olac, Bicester, U.K. and maintained under Home Office Regulations in 
the animal unit of the MRC Blood Pressure Unit, Western Infirmary, 
Glasgow. Animals were housed in a temperature-light-controlled room 
(Zl^^C; 12 hours light, 12 hours dark). All animal handling, surgery, 
dietary treatments, blood sampling and decapitation was done by Home 
Office Project licence holder. Dr. C.J. Kenyon except for those 
described in Chapter 3 which were performed by Dr. J.J. Morton, MRC 
Blood Pressure Unit, Glasgow. Normal and special low sodium rat 
chow was obtained from Special Diets Services, Witham, Essex. All 
animals were given food and water ad libitum. Before surgery animals 
were anaesthetised with sodium pentobarbitone. Mini osmotic pumps 
containing BrdUrd were inserted subcutanously into the back of the 
neck of all rats prior to treatment.
2.2. General Materials:
2.2.1. Chemicals and Reagents. 
The companies cited below are 
Bovine Serum Albumin 
5'-Bromo-2'-deoxyuridine 
Buffered Formaldehyde 
Captopril
Cellasolve 
Chloroform 
Coat-A-Count Kit 
Dexamethasone Acetate 
Diamino Benzidene 
Dimethyl Fomiamide 
Dimethyl Sulphoxide 
DPX Mountant 
Ethanol
Fast Red Violet LB Salt 
Fast Blue BB Salt
UK based unless otherwise stated.
- Sigma Chemical Company
" "
- Diagnostic Developments
- E.R. Squibb & Sons, Princeton,
N.J., USA.
- Genta Medical
- Genta Medical
- Diag. Product Co. C.A., USA.
- Sigma Chemical Company.
- Aldrich Chemical Company Ltd.
- Sigma Chemical Company
M «
- Merks Ltd.
- Customs and Excise Controlled 
“ Sigma Chemical Company
:
I
I
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Feulgen Kit
Glacial Acetic Acid 
Gurrs Eosin 
Histomount
Hydrogen Peroxide Concentrate
Hypertensin
Isopropanol
Levamisole
L-Nitro Arginine Methyl Ester 
Mayers Haematoxylin 
Methanol
Napthol AS-TR-Phosphate 
Paraffin Wax
Phosphate Buffered Saline Tablets
Poly-L-Lysine
Porcine Serum
Rabbit Serum
Silastic Curing Agent
Swine Serum
Trizma Base
TrizmaHCl
Trypsin
Xylene
Xylene Substitute
Cell Analysis Systems, Becton 
Dickinson Ltd.
BDH Laboratories 
Diagnostic Development 
Hughes & Hughes Ltd.
Merks Ltd.
Ciba Geigy, Basle, Switzerland
Genta Medical
Sigma Chemica Company
Diagnostic Developments 
Genta Medical
■ Sigma Chemical Company 
Bayer Diagnostics Ltd.
Mercia Dignostics
■ Sigma Chemical Company 
Gibco BRL
Scottish Antibody Production 
Unit (SAPU)
■ Dow Corning, Midland, USA. 
Gibco BRL
• Sigma Chemical Company
• ICN Biomedicals
■ Genta Medical
■ Life Sciences International
2.2.2. Antibodies:
Anti-Bromodeoxyuridine IgG Monoclonal Antibody - Europath Ltd. 
Rabbit-Anti Mouse Immunoglobulin/ Alkaline Phosphatase - Dako Ltd. 
Swine-Anti Rabbit Immunoglobulins - Dako Ltd,
Peroxidase-Anti-Peroxidase - Dako Ltd.
Rabbit Anti-Mouse Renin FAb fragments - Gift from Professor
K.Poulsen, Denmark. 
Ulex Europeus Lectin (Endothelial Cell Marker) - Vector Laboratories
2.2.3. Materials and Equipment: 
Glass slides 
Tissue cassettes
- Life Sciences International
- Bayer Diagnostics Ltd.
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Miniosmotic Pumps (model 2002) - Alzet, Palo Alto, CA, USA,
Coverslips - Life Sciences International
Microtome (rocking rotary) - Lab-Tek
Tissue Processor (Tissue-Tek) - Bayer Diagnostics Ltd.
Optomax V, Image Analysis System - Cambridge Instruments
CeU Analysis Systems 200 Image Analysis System - Becton Dickinson 
CCD Camera (JVC TK 870E) - JVC Ltd,
;
J2.3. Preparation of Solutions:2.3.1. Bromodeoxyuridine:0,5g of BrdUrd was dissolved in 2mls of dimethyl sulphoxide (DMSO) 
to give a concentration of 0,25mg/ml. 2mls of saline was added to the 
mixture to give a final concentration of 0.125mg/ml. 226jil of the <
BrdUrd solution was added to each pump and an estimated release of 
lOpVd gave each animal approximately 1,25mg BrdUrd per day.
2.3.2, Fixatives:
Methacam fixative was the preferred fixative for preserving nuclear 
DMA for all tissues. Methacam solution contained 60% methanol; 30% 
chloroform; 10% glacial acetic acid.
. r,
2.3.3. Buffers: |  
Tris Buffered Saline (TBS): lOmM Tris HCl, 2mM Tris Base. 150mM
NaCl, pH 7.2.
Phosphate Buffered Saline (PBS): 1 tablet dissolved in distilled water, 
pH 7,4. j::Veronyl Acetate Buffer: Stock Solution 1.94g sodium acetate trihydrate,
2.94g sodium barbitone/litre double distilled water. Working solution 
1ml stock/4ml water, pH to 9.2 with normal HCl.
2,3.4, Enzyme Substrates:
Peroxidase Substrate. 1 vial of DAB powder reconstituted in 10ml 
dimethyl formamide. Working Solution: Reconstituted DAB
Tris Buffer (0.05M), 250ml 
hnadizole, 25ml
Hydrogen Peroxide, 125pl |
Refer to appendix IV for substrate protocol.
Alkaline Phosphatase Substrate: Veronyl Acetate Buffer, pH 9,2
(10ml)
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5mg Levamisole
5mg Fast Red Violet LB or Fast
Blue BB
4mg Napthol AS TR Phosphate 
Refer to appendix I for substrate protocol.
2.3.5. Antibody Diluents:
All antibodies, with the exception of renin, were diluted in 1% bovine 
serum albumin (BSA) dissolved in TBS. Rabbit anti-mouse renin was 
diluted in 5% normal swine serum (NSS)/PBS,
2.3.6. Blocking Agents:
Endogenous enzyme activity was removed from tissues using either 
20% Normal Swine Serum diluted in PBS or 
15% Normal Rabbit Serum diluted in TBS
2.3.7. Angiotensin II:
Mini osmotic pumps were filled with All in 0.9% sodium chloride 
solution at a concentration between 5-7mg/ml depending on the weight 
of the rat. Pump capacity was 226 ± 6|il (mean ± standard deviation). 
The rate of infusion was 0.5 ± 0.02|il/h as tested previously in vitro by 
Griffin etal (1991) (126), Thus, a pump containing 6mg of All in a rat 
of 250g delivered peptide at 200ng.Kg"l.min"l.
2.4, Tissue Processing and Section Cutting:
Following 24 hour fixation in methacam solution, tissues were 
immersed in cellasolve and automatically processed through a series of 
chloroforms followed by infiltration with paraffin wax. Tissues were 
orientated and embedded in chucks containing molten wax. Section 
thickness was determined by the experimental requirements. Generally, 
3|xm thick sections were used except for sections of blood vessels 
analysed for ploidy (see Chapter 3c). All sections were cut, floated onto 
a waterbath at 58°C, mounted onto poly-L-Lysine coated microscope 
slides to prevent detachment of the section from the slide during 
trypsinisation (see appendix for protocol) and oven-dried at 60°C to 
enhance section-slide adherence.
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2.5. Staining and Immunostaining;
The immunocytochemical procedures used for all tissues were indirect 
methods which involve visualisation of the antigenic sites using two or 
more antibodies. The advantage of the indirect method' over the 'direct 
method' is that a greater proportion of antigen can be detected using a 
minimum concentration of primary antibody.
2.5.1. Renin:
Sections of kidney were dewaxed in xylene, immersed in absolute 
alcohol and submerged in 0.5% H202/methanol (see Appendix III) for 
30 minutes to remove endogenous peroxidase. Sections were washed in 
PBS and ringed using a wax pencil to prevent removal of the antibody 
from the section. lOOql of blocker (NSS/PBS) was added to each 
section to prevent background positivity, drained and blotted after 30 
minutes and replaced with rabbit anti-mouse renin (diluted 1/800, 5% 
NSS/PBS). Sections were incubated overnight at 4°C. Tissue sections 
were washed in PBS and incubated with swine anti-rabbit antibody 
diluted in 5% NSS/PBS for 30 minutes. After several washes in PBS 
the sections were conjugated with peroxidase anti-peroxidase antibody 
(PAP) diluted 1/1150 in 5% NSS/PBS for 30 minutes followed by 
washing in distilled water. Renin was visualised by immersing the 
sections for 8 minutes in diaminobenzidene (see Appendix iv) and 
appeared dark brown. For double-labelling of renin and BrdUrd in the 
kidney, sections were treated according to the method described in
2.5.2.
2.5.2. BrdUrd Immunostaining:
The alkaline phosphatase technique used for the detection of BrdUrd is a 
modification of that described previously by Ponder & Wilkinson, (161) 
and Mason & Sammons (162).
Tissue sections were cleared in xylene and hydrated through decreasing 
concentrations of alcohol into water. The sections were immersed in 0.7 
normal hydrochloric acid (NHCl) for 30-60 minutes at 37°C to 
hydrolyse the double-stranded DNA molecules and facilitate binding of 
the BrDUrd antibody to antigenic sites. Following several washes in 
distilled water, the sections were added to a solution of trypsin (ICN 
Biomedicals) at 37°C (see Section 2.5.3 for optimising trypsin). 
Following trypsinisation, the sections were washed vigorously in 
distilled water and submerged in TBS. The working solution for the 
primary antibody was optimum at a dilution of 1:20 (anti-BrDUrd in 1%
33
34
1
I
BSA/TBS) overnight at 4°C. The sections were carefully ringed with a 
wax pencil and lOOfi.1 of diluted antibody was added to each section. 
The sections were washed in 1% BSA/Tris and rabbit anti-mouse 
alkaline phosphatase antibody was applied at 1/25 diluted in 1% 
BSA/Tris for 60 minutes. BrdUrd was visualised by incubating each 
section with lOOpl of alkaline phosphatase substrate (see Appendix I), 
in the refrigerator in the dark for 10 minutes. To visualise BrdUrd- 
negative nuclei, sections were counterstained in haematoxylin (see 
Appendix v). Due to the solubility of alkaline phosphatase reaction 
product in non-aqueous solutions, the sections were taken immediately 
from water and mounted onto coverslips containing compatible aqueous 
mounting medium. BrdUrd-positive nuclei appeared either dark blue or 
red depending on the chromogen used. In negative control sections, the 
primary antibody was treated with either an antibody of the same 
immunoglobulin class not directed against BrdUrd or buffer.
2.5.3. Optimising trypsinisation
Trypsin digestion is normally used for revealing antigenic sites; 
although the mechanism is not entirely understood, it is thought that 
protein cross-links caused during fixation are released by the protease 
making more antigenic sites available to the antibody. The concentration 
of enzyme and duration of trypsinisation was dependent on the tissue 
type and had to be optimised separately for each tissue. In order to do 
this, a series of trypsin concentrations ranging from 0.01 %-2% diluted 
in TBS/Calcium Chloride were set up. Trypsinisation times ranged from 
30 seconds to 10 minutes. The detection of BrDurd in the adrenal gland 
was optimised at 0.03% trypsin for 2 minutes. The kidney required a 
lower concentration of trypsin for a longer time, 0.01% for 3.5 minutes 
and blood vessels were optimised at 0.1% for 2 minutes.
2.5.4. Ulex europeus lectin:
Sections were dewaxed and hydrated. Endogenous peroxidase was 
blocked with 3% H2O2 for 10 minutes. Sections were washed briefly 
in tap water and trypsinised for 20 minutes at 37°C. Following several 
washes in tap water a wax ring was circled around the sections and 
peroxidase-conjugated Ulex Europeus lectin diluted 1/200 BSA/Tris 
was applied and incubated on the sections for 30 minutes at room 
temperature. The sections were rinsed in TBS and washed for 10 
minutes in a TBS bath. The sections were then immersed in DAB
solution for 8 minutes, rinsed in tap water and the DAB chromogen was 
enhanced in weak 0.1% Copper Sulphate solution. Sections were 
counterstained with haematoxylin, dehydrated and mounted in DPX. 
Endothelial cells appeared dark brown.
2.5.5. Feulgen Staining of DNA:
■VlOjJ-m sections of blood vessels were dewaxed and hydrated. A Cell 
Analysis Systems (CAS) calibration slide consisting of an imprint of 
cultured rat hepatocytes, post fixed in 10% neutral buffered formalin, 
was included with each staining batch to ensure the quality of Feulgen 
DNA staining. The tissue sections were hydrolysed for 60 minutes in 5 
normal hydrochloric acid (5N HCl). The Feulgen stain containing 
Schiff s reagent and the blue chromogen thionine was supplied in kit 
form. The contents of one staining vial were dissolved in 100ml of 
O.IN HCl in 125ml Erlenmeyer flask. The flask was sealed with 
parafilm to prevent the emission of sulphur dioxide gas, and stirred for 
1 hour. The Feulgen stain reagent was filtered through grade #1 filter 
paper into Coplin jars. The slides were transferred from the 5N HCl into 
the stain reagent and left for 1 hour. The rinse solution was prepared by 
adding the contents of one vial of CAS rinse reagent containing 10% 
potassium bisulphate, to 300 ml of 0.05N HCl. The rinse solution was 
divided into three Coplin jars. Following staining, the slides were 
transferred into the first rinse for 30 seconds, the second rinse for 5 
minutes and the third rinse for 10 minutes. After washing in running tap 
water for 5 minutes, the slides were differentiated in 1% acid alcohol for 
a further 5 minutes to remove excess stain. Sections were dehydrated 
through graded alcohols, cleared in xylene and mounted in histomount.
'
2.5.6. Special Stains:
The special stains which were used to identify deposition of 
proteoglycans, collagen and reticulin deposition within blood vessels 
were as follows:
Proteoglycans- Alcian Blue Periodic Acid Schiff s (PAS).
Young and mature collagen and reticulin- Methyl blue van Gieson 
Muscle and collagen- Masson's Technique
The protocols for each special stain are summarised in Appendix VI-
vm.
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2.6. Plasma Enzyme/Steroid Measurements:
2.6.1. Plasma Renin Activity (PRA)\ Heparinised trunk blood was 
collected for measurement of PRA. This was kindly done in the MRC 
Blood Pressure Unit, Glasgow by Dr. J.J. Morton. In brief, the 
technique is based on the measurement of trapped angiotensin I 
generated by plasma when incubated with a known concentration of 
angiotensinogen (163).
2.6.2. Plasma Corticosterone Activity:
Heparinised trunk blood was collected, centrifuged and stored at -20^0 
until used. Plasma corticosterone was measured by radioimmunoassay 
as described by Morton et ah (164). This was kindly performed in the 
MRC Blood Pressure Unit by Miss Mary Ingram .
2.7. Blood Pressure;
Blood pressure was measured by a tail cuff method as described by 
Evdmetal (165).
2.8. Image Analysis and Cell Counting:
2.8.1. The Optomax V- Morphometry Image Analysis System:
The Optomax V-Morphometry Image Analysis System was used to 
measure the radius and medial area of all blood vessels. The system was 
initially calibrated using a stage micrometer and magnification objective 
X40. The stored calibration was used to automatically express the 
processed image from pixels (256 X 256) into micrometers. Only 
transverse sections of blood vessels were selected for measurement. The 
live image from the microscope was digitised using the CCD camera, 
captured and processed by the image analysis software (Vids-V 
Software) and transferred into a binary image which facilitated image 
segmentation. The portion of the blood vessel to be measured (e.g. 
media) was selected and thresholded by circling the appropriate area 
with a light pen applied to the television screen. This area was calculated 
and remaining areas (e.g. lumen) were excluded to give the radius and 
area of the media automatically.
2.8.2. CAS Image Analyser:
Sections of blood vessels were stained with the CAS Feulgen dye as 
described in section 2.5.5. Control slides containing intact cultured liver 
cells of known DNA content were stained simultaneously. Prior to
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calibration the light intensity was standardised to a reference light level 
stored in the computer memory. Calibration involved the assessment of 
the Feulgen stained calibration slide (see section 2.5.5). Computer 
automated selection of 40 tetraploid nuclei with a single peak and a 
coefficient of variation of less than 5% indicated acceptable staining 
quality as well as ensuring camera alignment and correct light setting. A 
threshold was set to achieve image segmentation, distinguishing smooth 
muscle cell nuclei from the background. Sections of blood vessel were 
selected at random and a minimum of 100 smooth muscle cell nuclei 
were analysed for ploidy status in vessels of all sizes in each mesenteric 
vascular bed. The data were presented as a histogram of nuclear DNA 
mass as described previously (166).
2,8.3. Cell Counting and the BrdUrd Index:
In random sections of adrenal gland, two thousand cells were counted in 
the zona glomerulosa, zona intermedia, outer and inner zona fasciculata, 
reticularis and medulla. Epithelial and endothelial cells which stained 
positively for BrdUrd were expressed as a percentage of the total 
number of cells counted in each zone. The BrdUrd index was calculated 
as follows:
BrdUrd Index -  Number of Stained Cells xlOO%
Total Number of Cells 
The cells were counted using a Zeiss Axiophot microscope and camera 
lucida frame which delineated a fixed area of 64ji^ at x40 magnification. 
Within each field of view, approximately two hundred and fifty cells 
were counted. Eight fields for each zone were selected at random to give 
a total count of two thousand cells. In the kidney, two thousand cortical 
cells were counted and the number of BrdUrd-positive cells was 
expressed either as a BrdUrd index or as the number of BrdUrd positive 
cells per 100 glomeruli.
In blood vessels, a BrdUrd index was obtained separately for 
endothelial, vascular smooth muscle cells and adventitial cells by 
counting all of the cells in each blood vessel layer. Blood vessels which 
had any damage to the endothelium were excluded from measurement.
2.9, Statistical Analysis:
2.9,1. Student's T~Test.
Morphometric variables, cell counts and BrdUrd Indices were compared 
between different groups of rats by calculating a mean for each rat and
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then applying a two-sample t-test As judged by Kolmogorov-Smirnoff 
and F tests, the distributions of these means were compatible with the 
assumptions of normality and equality of variance on which the t-test is 
based.
2.9.2. Cumulative Distribution Function:
The medial areas of blood vessels were ranked for each experimental 
group in ascending order and grouped into centiles according to the 
method described by Short (167). To assess whether treatment had 
effects on a sub-population of arteries which could lead to an altered 
shape of distribution, the pooled measurements of individual arteries 
were used to construct a cumulative distribution curve for each group of 
rats. The difference between control and test curves was measured in the 
direction of the medial area and was expressed as a percentage change in 
area compared to the control values. The estimated change in area could 
then be plotted as a function of the control area.
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THE RENIN ANGIOTENSIN SYSTEM AND DNA 
SYNTHESIS IN THE KIDNEY, ADRENAL GLAND AND 
MESENTERIC BLOOD VESSELS.
The first chapters of this thesis refer to three experiments 
designed to investigate the effects of manipulations of the renin- 
angiotensin system on DNA synthesis in some of its target tissues. The 
effects of treatment with All, captopril and low and high dietary sodium 
on the kidney, adrenal gland and mesenteric blood vessels are described 
separately in chapters 3 a-c but refer to the same groups of animals. 
Chapters 4 and 5 describe separately the effects of nitric oxide synthase 
inhibition and administration of glucocorticoids on DNA synthesis of 
various tissues.
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C hapter 3a: DNA SYNTHESIS AND THE SYSTEMIC 
AND INTRARENAL RENIN-ANGIOTENSIN SYSTEMS.
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Introduction:
An is the major effector peptide of the renin-angiotensin system 
and, although it is generally regarded as a circulating hormone, there is 
also strong evidence of an intrarenal renin-angiotensin system (41,
168). All of the components required for generation of All have been 
localised within the kidney including angiotensinogen (31) renin (40) 
angiotensin I, ACE and angiotensinases (41). Intrarenal synthesis of 
some of them has been established by finding intrarenal mRNAs (169,
170). In addition, local concentrations of All have been found in renal 
tissue (51) and in specific intrarenal fluid compartments of rats (171) 
which are higher than systemic concentrations. These high levels of All 
are increased by sodium intake and blockade with ACE (52). In 
addition, AH has been identified in JO A cells of rat kidney although it is 
not known whether it is synthesised in situ or absorbed from elsewhere 
(40, 172).
Goldblatt has suggested that the kidney evolved an intrinsic 
renin-angiotensin system which only later became adapted as a 
circulating hormone system (173). The role of this intrinsic system as a 
m^or modulator of renal function is generally recognised (49,174). All %iiinfluences intrarenal haemodynamics in several ways: by eliciting dose-
dependent decreases in renal blood flow and by smaller more variable W
effects on glomerular filtration rate (GFR), such that filtration fraction
increases (49). Locally generated All may reduce inner cortical blood
flow to a greater extent than circulating All (175).
Although these physiological effects of All indicate a functional 
intrarenal renin-angiotensin system, there is little information on the role 
of All in the regulation of renal cell growth in vivo. Many of the renal 
cell types possess All receptors (43, 44. 176) and, in vitro, All 
promotes hypertrophy of mesangial cells (177) and proximal tubular 
cells (59). In vivo, analysis of the role of specific growth factors is 
complicated by heterogeneity of the cell types in the kidney each with 
different rates of turnover. In addition, growth factors may also have 
different effects on epithelial, endothelial, interstitial or contractile cells 
(54). In vivo it is difficult to distinguish between direct growth effects
of All from secondary haemodynamic effects induced, for example, by 
vasoconstriction.
In the normal adult mammalian kidney, renin is synthesised in 
afferent and efferent arterioles and interlobular arteries (174). The 
intrarenal distribution of renin changes markedly during maturation 
(178), adrenalectomy (30) and renal artery constriction (30) and it has 
been proposed that changes in the distribution of renin may be important 
in the stabilisation of renal perfusion pressme (179). Furthermore, it has 
been shown that chronic stimulation of the renin-angiotensin system 
increases the fraction of renin-secreting ceUs along the afferent arteriole 
(30, 33). Dietary sodium restriction and converting enzyme blockade 
increase the granulation and number of renin-secreting cells (30, 180). 
The mechanism by which renin secreting cell number increases is 
controversial. Histological studies have described mitotic figures in cells 
of the JGA (181, 182) suggesting that cell proliferation may contribute 
to their increased number. Others have failed to show an increase in 
DNA synthesis (183) and have argued that existing smooth muscle cells 
in the afferent arteriole are recruited and transformed into granular 
epithelial cells in response to stimulation (30, 33,41,183),
In part, the controversy has arisen because of the difficulties in 
detecting small increases in proliferation in cells which normally 
turnover slowly, or, as with the adaptation of rats to conditions of 
altered intake of dietary sodium, where the problem is complicated by 
the slow time course of events.
In order to investigate the effects of All as a renal growth factor 
in vivo, the renin-angiotensin system was manipulated over two weeks 
in several ways. Firstly, All was infused into rats. The main objective 
of this was to promote the systemic renin-angiotensin system but inhibit 
the local production of renin/AIL This would help to discriminate 
between systemic and paracrine growth effects of AIL Also, since the 
mechanical effects blood pressure are also important in cell growth, a 
dose of All which was known to raise blood pressure by a slow 
mechanism was infused into rats.
Secondly, the renin-angiotensin system was stimulated by 
adaptation of rats to low dietary sodium. Low dietary sodium is known 
to raise All levels but decrease the pressor activity of All and other 
vasoactive hormones such as catecholamines or vasopressin (184,185). 
Thus, dietary sodium restriction would raise both the intrarenal and 
systemic All concentration and would determine whether any growth
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effects mediated by All on the kidney are direct or secondary to blood 
pressure changes.
Thirdly, rats were given the converting enzyme inhibitor, 
captopril to inhibit the systemic conversion of AI to All. This would 
drive the intrarenal renin-angiotensin system and promote increased 
renal renin/AII levels. It was hoped that this would distinguish between 
the systemic and paracrine or autocrine growth effects of AIL
The length of time given to the rats to adapt to treatment was 
considered appropriate to demonstrate changes in growth of all renal cell 
types including those which turnover slowly such as mesangial cells and 
smooth muscle cells of the afferent arteriole. The end result included all 
DNA synthesis which took place over two weeks.
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Materials and Methods:
a) Rats:
Animal treatments described below are applicable to chapters 3a-c. 
Groups of six, adult, male Sprague-Dawley rats (250g) were 
anaesthetised using sodium pentobarbitone and were implanted with 
miniosmotic infusion pumps subcutaneously at the back of the neck. 
BrdUrd was infused continuously for 14 days.
Angiotensin II:
In one group All was infused via a second minipump at a rate of 
200ng.Kg“l.min"i for 14 days whilst pumps in the control group 
contained vehicle. Systolic blood pressure was measured after treatment 
in concious warm rats using a tail-cuff method (165).
Dietary Sodium:
One group of rats received a special low sodium diet for 14 days A 
second group also ate the low sodium diet and received sodium 
supplements in the form of 1.5% NaCl in drinking water.
Captopril:
Captopril was administered in drinking water (0.5mg/ml; approx 
lOmg.kg-l.d-^). Dose was calculated on an average fluid intake of 
20ml.kg.d. The control group drank tap water alone. All rats had free 
access to food and water.
b) Renin: After 14d, heparinised trunk blood was collected for 
measurement of plasma renin activity (163).
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c) Tissue Processing:
Treatment of tissues are described in detail in Chapter 2. In brief, rats 
were killed by a blow to the back of the head followed by decapitation. 
Tissues were removed and fixed in Methacam solution and processed to 
paraffin wax. Sections of kidney were double immunostained for renin 
and BrdUrd, whilst adrenal gland and blood vessels were stained for 
BrdUrd only. All sections were counterstained with haematoxylin.
d) Quantification:
i) Renin-Secreting Cells: All nucleated renin-secreting cells were 
counted in three transverse kidney sections firom each rat and divided by 
the total number of glomeruli.
ii) BrdUrd-containing nuclei: Using a x40 objective the renal cortex was 
scanned. A minimum of 2,000 cells per kidney were counted in 
glomeruli, tubules and interstitium. The renal arterial tree was also 
examined for the presence of BrdUrd-positive nuclei.
e) Statistics: Data were analysed by unpaired Students' t test.
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Results;
Distribution ofBrdUrd-positve nuclei:
The highest concentration of BrdUrd-positive nuclei was in the 
tubular epithelial cells of the deep renal cortex (refer to Fig.3.1); there 
were few labelled nuclei in the medulla. Labelled nuclei in the distal 
parts of proximal tubules and in the thick loops of Henle in the deep 
cortex were distributed as focal aggregates. In the glomeruli the majority 
of labelled cells were in the mesangium (Fig.3.2) although occasional 
endothelial and epithelial cells were also positively stained. BrdUrd- 
positive nuclei were regularly identified in vascular smooth muscle cells 
and in endothelial cells in each section, however, no renin-containing 
cell stained positively for BrdUrd (Fig.3.3).
Angiotensin II Infusion:
After two weeks, blood pressure increased significantly (All 
177± 11.1 S.E.M; cf control 131.5+ 5.3 mmHg, p<0.05); plasma renin 
activity was reduced to almost undetectable levels and the number of 
renin-secreting cells decreased (Fig.3.4a). The distribution of 
immunostainable renin was restricted to JG cells at the glomerular 
vascular pole. In some JGA's of rats treated with All, renin was 
undetectable. In All-treated rats DNA synthesis increased in glomeruli 
but there was no significant effect on tubules or interstitial cells 
(Fig.3.4b).
Dietary Sodium Manipulation:
Compared with rats fed a sodium supplemented diet, plasma 
renin activity was higher and the number of renin-secreting cells was 
twofold greater in rats fed a low sodium diet (Fig,3.5a). In the low 
sodium group, renin-secreting cells were located predominantly at the 
vascular poles but also extended along the arterioles where, in some 
sections, they were distant from the JGA. This contrasted with the high 
sodium group where renin-positive cells were detected only at the 
vascular pole (Fig.3.5b). Despite high plasma renin activity, low dietary 
sodium had no effect on DNA synthesis in glomeruli, tubules or 
interstitial cells (Fig.3.5a).
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Angiotensin Converting Enzyme Inhibition:
Treatment with captopril increased plasma renin activity and the 
number of renin secreting cells (Fig,3.6a) compared with the controls. 
The distribution of renin in captopril-treated rats was similar to that of 
the low sodium group (Fig.3. 6b). Opposite to the effects of All 
infusion, captopril reduced the number of glomerular BrdUrd-positive 
nuclei (Fig.3.6b). As with the other experimental groups, captopril had 
no significant effect on tubule or interstitial cell DNA synthesis 
(Fig.3.6a).
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Discussion
1) Proliferation of Renin-Secreting Cells:
Treatment with ACE inhibitors or dietary sodium restriction 
promotes activity of intrarenal renin-angiotensin systems (33, 34, 52, 
170) whose functions, amongst many, may be to promote renal cell 
growth (54). Treatment with low dietary sodium or captopril are two 
means by which renin secretion and All within the kidney may be 
raised. Low dietary sodium, by increasing renin secretion promotes All 
which is required for the subsequent synthesis and secretion of 
aldosterone to retain sodium. Captopril, by inhibiting converting 
enzyme, lowers plasma All concentration and blood pressure which 
both stimulate renal renin secretion. (19).
Following either treatment, the greater demand for renin results 
in an increased number of renin-secreting cells within the kidney. 
However, the mechnism for this response is controversial and it is not 
clear whether renin-secreting cell numbers increase because of 
hyperplasia or metaplasia. The use of a double-labelling technique with 
antibodies to renin and BrdUrd and experiments with captopril and low 
sodium diet were intended to show whether renin-secreting cells within 
the renal arterioles proliferate in response to stimulation.
Two enzyme substrates, fast red violet and fast blue were used 
independently to detect BrdUrd in conjunction with the horseradish 
peroxidase reaction for renin. Fast red violet and Fast blue b) have 
different absorption spectra from each other and are both readily 
distinguishable from diaminobenzidene, the chromogen used in the 
peroxidase reaction. Despite an increase in the number of 
immunoreactive renin secreting cells within the kidney with low sodium 
or captopril, there was no DNA synthesis in any renin-secreting cell. 
The result was the same whether Fast red or Fast blue was used to 
detect BrdUrd These results agree, in part, with Cantin et al (1977) 
(183) who failed to show an increase in tritiated thymidine ([^HJTdR) 
uptake following development of the ischaemic (endocrine) kidney. This 
experimental model involves the partial ligation of the aorta between the 
renal arteries with a consequent reduction in renal blood pressure to one 
kidney. Since low blood pressure is a stimulus for renin secretion, 
ligation results in an increase in renin-secreting cell number within the 
JGA and arterioles. However, the lowering of blood pressure may alone 
have removed a stimulus for vascular smooth muscle cell growth in the
51
arterial walls. In the present study, blood flow was not restricted, yet 
neither treatment with low sodium or captopril had any effect on DNA 
synthesis in the renal arteriole. It would appear, therefore that cell 
proliferation is not a component of the adaptation of the renal arteriole to 
stimulation. ofStimulation increases the number renin secreting cells and renin 
gene expression within the afferent arterioles (33). This has lead to 
speculation that existing cells within the arteriole are recruited and 
phenotypically transformed into myoepithelioid cells by metaplasia (30, 
33,41,183). Others believe that migration of smooth muscle cells is 
possible (264). However, the mechanisms responsible for the changes 
in distribution of renin gene expression remain largely unknown and 
require further study.
2) All as a Growth Factor for Tubular and Interstitial Cells:
It has been demonstrated that all renal tissue All and up to 50% 
of renal venous All are of intrarenal and not systemic origin (186). The 
physiological significance of intrarenal All is unclear. Mendelson et al 
have demonstrated high density All receptors in the superficial and deep 
cortex of the kidney (187). Glomerular All receptors are distributed 
predominantly in mesangial cells (43, 187) whilst the highest density of 
All receptor binding sites are in proximal convoluted tubules (176) and 
to a lesser extent in renomedullary interstitial cells (188). The functional 
role of these receptors with regard to the regulation of salt and water 
metabolism is only partially known (49) and it is possible that they also 
mediate the growth-promoting effects of All formed either intrarenally 
or systemically (54).
Treatment with low dietary sodium, which raises both intrarenal 
renin/AII and systemic renin/AII, had no significant effect on DNA 
synthesis in any renal cell type, indicating that All does not appear to 
have direct intrarenal or systemic effects on renal cell growth in vivo. 
Furthermore, neither All infusion which potentially increases systemic 
and decreases intrarenal All simultaneously, nor captopril with opposite 
effects on All control, had any significant effect on interstitial or tubular 
cell growth. Surprisingly, when systemic All was raised by infusion, a 
negative trend on growth of interstitial cells was observed. It is possible 
that a significant result might have been achieved if the response of 
particular tubules and renal cell types were noted separately. Also, 
knowledge of plasma and local tissue All values and plasma renin
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activity would have allowed a precise distinction between systemic and 
paracrine responses.
The present observation that tubular and interstitial cells do not 
proliferate in response to manipulations of the renin-angiotensin system 
contrast with those of Johnson et al (189), who using PCNA expression 
as a marker of DNA synthesis, claimed that All increased proliferation 
in tubule and interstitial cells. In this instance, however, the dose of All 
was almost fourfold greater than that used in the present experiments 
resulting in severe hypertension with consequent renal injury. There 
was also evidence of leukocyte infiltration, tubular damage and 
interstitial fibrosis. Since cytokines produced by neutrophils are gi'owth 
factors (190), it is difficult to assess whether the growth effects were 
mediated directly by All or by haemodynamic effects of All or as a 
result of the immune response to injury. Furthermore, this study is 
subject to error. It is well established that PCNA is functionally active 
during periods of unscheduled DNA replication, including DNA repair, 
with the result that PCNA antigen overestimates cells which are in cycle 
(191). Renal damage alone, therefore, could increase PCNA expression 
by stimulating regeneration.
3) All as a Growth Factor for Mesangial Cells:
The role of AH as a growth factor for vascular smooth muscle 
cells has been studied extensively, particularly as a mediator of blood 
vessel hypertrophy in hypertension (192). The similarity between 
vascular smooth muscle and mesangial cells suggest that the 
mechanisms proposed for the All-induced growth of vascular smooth 
muscle cells may also apply to the mesangium.
The lack of an effect of low or high dietary sodium on mesangial 
cell DNA synthesis contrasts with increased DNA synthesis following 
All infusion. The main differences between All raised by infusion and 
by low sodium are haemodynamic. All infusion raised blood pressure 
significantly resulting in mild hypertension whereas low sodium blunts 
vascular pressor responsiveness both directly, by downregulating
. .receptors to pressor agents such as All and norepinephrine (78, 185), 
and, indirectly, by extracellular fluid volume depletion. For these 
reasons, low dietary sodium has been used clinically as a tieatment for 
hypertension. High blood pressure increases smooth muscle tension and 
hence may induce expression of growth proto-oncogenes (142). The 
angiotensin receptor subtype ATI mediates most of the vascular and
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renal proximal tubular actions of AH (193, 265). Down regulating these 
receptors by feeding a low sodium diet may result in decreased pressor 
responsiveness, lower blood pressure and reduced smooth muscle cell 
stretch, which could remove a stimulus for growth. Conversely, All 
infusion promotes high blood pressure with increased stretch which 
could explain increased mesangial cell DNA synthesis in response to AH 
infusion. Likewise, reduced mesangial cell DNA synthesis in response 
to captopril may be associated with reduced blood pressure. The 
insensitivity of rat mesangial cells to the proliferative effects of All have 
been confirmed in vitro, although AH did induce an increase in protein 
synthesis (177).
4) Does Blood Pressure Influence the Response to All:
Changes in vascular smooth muscle cell growth are normally 
associated with high blood pressure. It is not fully known whether AH 
acts as a smooth muscle cell growth factor in vivo, whether blood 
pressure can, alone, stimulate growth or whether there is a requirement 
for both factors in order for cells to synthesise DNA. In the Goldblatt 
two-kidney, one-clip model, rats develop a renin-dependent form of 
hypertension (113). This model has been used extensively to study 
independently the role of blood pressure in the control of renin 
secretion. It is known that renal artery clipping results in a sustained 
increase in plasma renin activity and a subsequent rise in blood pressure 
to the unprotected, hypertensive kidney. This results in renovascular 
hypertension with the rise in blood pressure also sustained by vascular 
hypertrophy. The clipped kidney receives raised All but is protected 
from the increase in blood pressure. Using this experimental model, 
Eng et al (194) demonstrated an increase in DNA synthesis in all renal 
cell types of the hypertensive kidney, but little or no change in growth in 
the protected kidney, and concluded that both raised pressure and All 
are a pre-requisite for growth. The Goldblatt model is similar to the 
present study where low dietary sodium represents the clipped kidney 
being exposed to raised levels of All in the absence of a rise in pressure. 
The clipped kidney, on the other hand, parallels the effects of All 
infusion being exposed to both high All and blood pressure. The lack of 
an effect of low dietary sodium on renal cell growth suggests that AH 
may not be involved in renal cell growth in vivo, but increased blood 
pressure is probably a pre-requisite for growth. The conclusions that 
Eng et al derived from their experiments are flawed in that they had no
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evidence in support of growth effects of All. An independent study 
based on raising blood pressure without altering the activity of the renin- 
angiotensin system is required to clarify the role of All in renal cell 
growth. Ideally, blood pressure measurements for all animals would 
have been appropriate for this study, however, while the tail-cuff 
method is useful for detecting relatively large positive increments in 
blood pressure with AH, it is not suitable for detecting smaller negative 
changes in otherwise normotensive rats. A more sensitive method for 
studying subtle effects of captopril and dietary sodium on blood 
pressure would have involved cannulation of a major artery which 
would have compromised growth aspects of this study.
In conclusion, increased numbers of renin-secreting cells caused 
by dietary sodium restriction and captopril treatments are due to 
metaplasia and not changes in cell proliferation. Increased and decreased 
DNA synthesis in renal glomeruli in response to angiotensin II and 
captopril are accounted for by known changes in intrarenal 
hamodynamics and not exclusively by effects on systemic concentration 
of angiotensin II. Intrarenal changes in angiotensin H, which may have 
been expected in response to the various treatments, had no significant 
paracrine or autocrine effects on DNA synthesis in tubule or interstitial 
cells.
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C h a n ter  3 h : THE EFFECTS OF MANIPULATIONS OF 
THE RENIN-ANGIOTENSIN SYSTEM ON DNA 
SYNTHESIS IN THE RAT ADRENAL GLAND 
Introduction:
Aldosterone secretion by the adrenal zona glomerulosa is 
controlled predominantly by the renin-angiotensin system. In vivo, 
angiotensin II specifically stimulates the zona glomerulosa to secrete 
mineralocorticoids with no apparent direct effects on glucocorticoid 
secretion. Evidence for a zone specific role for All is derived firstly 
from studies with low dietary sodium which increases both plasma renin 
activity and plasma All levels (77, 195), upregulates zona glomerulosa 
All receptors (77) and increases the biosynthetic capacity of the zona 
glomerulosa (196). Secondly, whilst the zona fasciculata and reticularis 
atrophy following hypophysectomy, the glomerulosa remains intact, 
indicating only partial regulation by ACTE (2). Thirdly, All in vitro 
stimulates steroidogeneis in isolated rat zona glomerulosa cells and not 
in fasciculata/reticulatis cells (197),
There are several mechanisms whereby All stimulates 
aldosterone secretion. The acute response to All is mediated through 
high affinity zona glomerulosa cell receptors, an effect which can be 
totally blocked by the ACE inhibitor captopril (77). In the longer term 
All also controls, in part, the expression of some of the enzymes 
involved in the synthesis of aldosterone (81, 198) and increases the size 
of the mitochondrial and lipid compartments of the cell (63) where the 
steroid enzymes are secreted and lipid is stored (199). In addition, 
Hartcroft & Hartcroft (180) described an increase in zona glomerulosa 
width in response to dietary sodium restriction. However, whether this 
increase in glomerulosa width is associated with cell proliferation as 
well as cell hypertrophy remains to be investigated. Other actions of All 
in the adrenal gland include its role in intra-adrenal renin-angiotensin 
systems. Renin and All concentrations in the zona glomerulosa vary 
with the plasma electrolyte status (60).
According to Race and Green (96), individual zones of the 
cortex are responsible for maintaining their own cell populations in 
response to increased functional demand. The evidence for this is 
controversial. Some studies have shown that although cells proliferate in 
the outer zones, the new cells are subsequently displaced inwards to
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replace cells which die (85, 86, 93, 200). The evidence for the zonal 
theory is based on several lines of evidence: Ogishama et al (201) 
demonstrated zone-specific expression of aldosterone synthase 
cytochrome p-450aldo (zona glomerulosa) and cytochrome p-450118 
(zonae fasciculata/reticularis) indicating relative functional independence 
of the adrenocortical zones; administration of renin increased zona 
glomerulosa width in rats (202); the zona reticularis, which is 
commonly regarded as the apoptotic zone of the cortex, has All 
receptors present on these cells albeit to a lesser extent than the zona 
glomerulosa (203), indicating probable functional significance of All 
within this zone.
Stimulation of the adrenal medulla is mediated largely through 
the action of nerves which synapse on chromaffin catecholamine- 
secreting cells to promote secretion. Secretion is, in part, also controlled 
by All which binds either directly to specific receptors on chromaffin 
cells (204) or indirectly by increasing sympathetic nervous system 
activtiy (5). Low blood pressure is a known stimulus for catecholamine 
secretion (205, 206), however, it is not known whether changes in 
growth of the cells are a component of this response and whether 
growth effects of All are involved. Changes in chromaffin cell 
proliferation have been described in response to physiological 
stimulation (207).
The first aim of this study, therefore, was to assess whether the 
adaptation of zona glomerulosa to continuous stimulation with All 
involved changes in DNA synthesis. All was raised systemically by 
infusion or by dietary sodium depletion and was inhibited by treatment 
with captopril. The second aim was to examine whether changes in 
DNA synthesis are zone specific or whether growth effects of All are 
more diverse within the adrenal gland. DNA synthesis was assessed 
over a two week period by the continuous infusion of BrdUrd.
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Materials & Methods:
As described for Chapter 3a.
Results:
Histology
Except for rats treated with captopril, the zona fasciculata was 
clearly delineated from the zona glomerulosa by the zona intermedia 
comprising small cells 3-5 cell layers thick, with relatively little lipid 
content and few BrdUrd-positive nuclei. In all zones of the cortex and 
the medulla, epithelial cells were distinguished from non-epithelial cells 
by being bigger and having rounder and larger nuclei. Staining with 
Ulex europeus lectin and immunohistochemistry indicated that most of 
the non-epithehal cells were endothelial (refer to Fig.3.7).
With the exception of the zona glomerulosa, the numbers of 
epithelial and non-epithehal cells were similar. BrdUrd indices tended to 
be greatest in the zona glomerulosa and outer zona fasciculata and least 
in the inner zona fasciculta and reticularis. Within the zona glomerulosa 
BrdUrd-positive nuclei were uniformly distributed.
Angiotensin II Infusion:
All infusion increased blood pressure (All 177± 11.1 S.E.M; cf 
control 131.5± 5.3 mmHg, p<0.05) and increased the width of the zona 
glomerulosa (Fig 3.8a). Epithelial zona glomerulosa cells, grouped 
together in aggregates, were enlarged and contained abundant 
cytoplasmic lipid (Fig 3.8a). Half of the epithelial cells had BrdUrd- 
positive nuclei, threefold more than controls (p<0.001) (Fig.3.8c). In 
non-epithelial zona glomeinlosa cells and in epithelial and non-epithelial 
zona intermedia and zona fasciculata cells, the BrdUrd-index was 
unaffected by treatment.
In the zona reticularis, at the interface with the medulla, groups 
of BrdUrd-positive cells were abundant in adrenals from All-treated rats 
(Fig.3,8b). The BrdUrd indices of non-epithelial cells in the zona 
reticularis and of both cell types in the medulla were lower in All-treated 
glands.
Dietary Sodium Manipulation:
Compared with rats fed a high sodium (supplemented) diet, the 
pattern of response of the adrenal gland to sodium restriction was 
similar to the effects of All (3.9c). The zona glomerulosa was wider
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with larger epithelial cells many more of which contained BrdUrd- 
positive nuclei (3.9a). As with All treatment, the BrDurd-index of zona 
reticularis epithelial cells was increased with dietary sodium restriction 
(Fig.3.9b). However, unlike All treatment, dietary sodium restriction 
did not affect DNA synthesis in the medulla.
Captopril Treatment:
Captopril treatment markedly reduced zona glomerulosa width 
but had little effect on BrdUrd labelling. (Fig.3.10c). However, the 
morphology of epithelial zona glomerulosa cells was very different from 
controls (Fig.3.10a). Small cells with lipid-deplete cytoplasm and 
pyknodc nuclei were arranged in irregular clumps. The BrdUrd index in 
non-epithelial cells of inner zona fasciculata and reticularis was lower 
after captopril, whereas twice as many of the epithelial cells of the 
medulla were positive (Fig.3.10b).
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cells are  brown.
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F ig .3 .8a . The effects o f  A ll  infusion on DNA syn th esis in th e zon a  g lo m eru lo sa  
(LG ). A ngiotensin  II (A ll), C ontrol (C on). The zona in term edia (71) c lea rly  separa tes  
the LG fro m  the zona fa sc icu la ta  (LF).
' # 1
&
HS
F ig .3 .9a . E ffects o f  low  an d  high d ie ta ry  sodium  on D NA syn th esis  in the zona  
glom erulosa. N ote increased zonal w idth with low  sodium .
F ig .3 .10a . The effects o f  ca p to p r il treatm ent on the zon a  g lom eru losa . The c e lls  
appear sm aller and the zone is reduced in width.
61
?
...
M
» All
;V .
% * t
* .  " :t! .J :  Con
F ig .3 .8b . The in terface betw een  the cortex  and m edu lla  sh ow in g  in crea sed  DNA  
synthesis in the reticu laris fo llow in g  A ll infusion.
•  I
% -*■ -n
#
/
HS
F ig .3 .9b . The effects o f  low  and high d ie ta ry  sodium  on the zona  re ticu la r is  and  
medulla.
Capt
W :
#
# #
# •
m
 ^ 4
•  •
#
.  •
.  *
•  •
1 •
»" 1 #
1:'
Con
F ig.3 .10b. The effects o f  cap topril on DNA synthesis in the reticu laris/m edulla .
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Discussion;
Adult male rats were selected for this study to avoid any 
prepubertal (208) or oestrus-related (209) changes in proliferative 
activity and the timecourse of the study avoided any changes in growth 
associated with circadian rhythm (210).
In the control groups, maximal DNA synthesis occurred in the 
zona glomerulosa and outer zona fasciculata. This is consistent with 
previous reports of mitotic activity in the adult male rat (87, 200). 
Interestingly, those cells which had incorporated BrdUrd, were situated 
on either side of an almost unlabelled, clearly delineated, zona 
intermedia which appeared not to change even when the cortex was 
stimulated with AH. The lack of DNA synthesis in the zona intermedia 
is in accord with Engstrom (211) and van Dorp & Deane (80) but 
contrasts with Mitani et al (81) who, also using BrdUrd, described the 
zona intermedia as being a novel stem cell zone with apparent 
proliferative activity. The main disadvantage of the latter study, 
however, is the timecourse used to demonstrate changes in DNA 
synthesis. BrdUrd administered by single injection following low 
dietary sodium for a period of hours rather than days, whilst showing 
some labelling, is an insufficient time for the adrenal gland to adapt 
properly to alterations in diet.
An raised by infusion and by low dietary sodium both increased 
DNA synthesis in epithelial cells of the zona glomerulosa and caused a 
twofold increase in zona glomerulosa width. It would appear, therefore, 
that cell growth is an intrinsic component of the zona glomerulosa in 
response to increased activity of the renin-angiotensin system. In 
addition, many zona glomerulosa cells were enlarged and contained 
abundant hpid. These cells also have enlarged mitochondria and a more 
extensive smooth endoplasmic reticulum (98, 212), the organelles 
which are responsible for steroid synthesis (199). The growth effects 
are specific to the rise in All since zonal atrophy occurred following 
treatment with captopril. Although, in this instance, the BrdUrd index 
was unchanged, there was nuclear pyknosis and atrophy of cells of the 
zona glomerulosa which had not incorporated BrdUrd indicating that 
cell death also probably occurred. Since the BrdUrd index was based on 
the number of BrdUrd-positive cells as a proportion of all cells within 
the zone, increased cell death would probably be reflected by a higher 
BrDurd index. Although DNA synthesis was probably reduced in the 
zona glomerulosa, programmed cell death may also have occurred
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following withdrawal of the trophic stimulus, this may have 
obscured an increase in the BrdUrd index. Despite evidence that the zona 
reticularis is the zone where cells die by apoptosis (2), the effect of 
captopril this study raises the possibility that cell death also occurs 
zonally. Although Wyllie et al (2) demonstrated increased apoptosis only 
in the inner zones of the cortex following dexamethasone treatment or 
hypoxia, there are few other experiements to show that cell death also 
occurs in the outer zones.
Low sodium and All infusion increased epithelial cell DNA 
synthesis in the zona reticularis, independent of any changes in the zona 
intermedia or zona fasciculata. Furthermore, treatment with captopril 
caused a reduction, albeit small, in epithelial cell DNA synthesis in the 
reticularis. These results imply that All could also act as a specific growth 
factor for cells of the zona reticularis. The lack of a growth effect of All 
on the epithelial cells of the zona fasciculata despite changes in the zona 
reticularis argues against the migration theory.
AH infusion caused a decrease in DNA synthesis in the adrenal 
medulla, in contrast to low sodium which had no effect. Opposite to the 
effects of All, captopril caused an increase in medullary cell DNA 
synthesis. It would appear, therefore, that All does not have a direct 
growth-promoting effect on the adrenal medulla but may have influences 
mediated by haemodynamic processes. Although, under normal 
circumstances, raised systemic AH stimulates sympathetic activity and 
promotes catecholamine secretion (5), it is possible that prolonged 
infusion of AH which increases blood pressure also results in reduced 
demand for catecholamines to compensate for the rise in blood pressure. 
Similarly, the hypotensive effects of captopril are perhaps compensated 
by increased catecholamine secretion which is enhanced in response to 
hypotension (110).
Immunostalning with the lectin, Ulex europeus, demonstrated 
that the majority of non-epithelial cells within the adrenal gland were 
endothelial. Although the effects of manipulating the renin-angiotensin 
system on DNA sythesis of these cells are difficult to interpret and appear 
not to be specific, it is known that adrenocortical secretory activity can be 
modulated by changes in blood flow (110). Since vasoreactivity is 
modulated by vasoactive substances secreted by endothelial cells, it is 
possible that changes in DNA synthesis of adrenocortical endothelial cells 
reflects changes in adrenal haemodynamics.
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ilIn conclusion, increased DNA synthesis contributes to the hypertrophy of the zona glomerulosa which occurs in longterm 
increased activity of the circulating renin-angiotensin system. All 
appears to be a specific growth factor for zona glomerulosa and zona 
reticularis cells in vivo. The lack of growth effects in other zones 
supports the zonation theory of cytogenesis and suggests that cell 
proliferation is an important component of the response of the adrenal 
cortex to stimulation. The changes in DNA synthesis in the adrenal 
medulla are probably due secondary to variations in the demand for 
catecholamines caused by changes in systemic blood pressure.
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Chapter 3C: VASCULAR HYPERTROPHY AND THE 
RENIN-ANGIOTENSIN SYSTEM 
Introduction:
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Structural alterations of the vascular wall play an important role
in the pathogenesis and perhaps the aetiology of hypertension (114, 
213). Three important changes have been identified in blood vessels: 
hyperplasia, which is an increase in the number of smooth muscle cells 
by cell division; cellular hypertrophy which is an increase in the size of 
existing smooth muscle cells and remodelling which is an a 
rearrangement of existing cells around a smaller lumen (118).
The factors which contribute to cardiovascular growth are 
complex and although there is a strong genetic component in essential 
hypertensive patients and in genetically hypertensive rats (214, 215), 
other physiological factors are also involved. The renin-angiotensin 
system is implicated both in the control of blood pressure and in the 
control of hypertrophy. Treatment of SHR strains with ACE inhibitors 
prevents the development of hypertension and reverses cardiovascular 
hypertrophy (215) whereas replacement of All during ACE inhibitor 
treatment restores hypertrophy (215). In vitro. All promotes 
mitogenesis of vascular smooth muscle cells Û30, 131) protein 
synthesis (116) and activates some of the proto-oncogenes responsible 
for growth (265). Taken together, these data suggest that All plays an 
important role as a cardiovascular mitogen.
Investigations of the effect of AH on blood vessels are limited by 
the techniques employed. For example, myography has demonstrated 
hypertrophy in blood vessels following AH infusions, however the 
range and size of blood vessels selected for measurement are restricted 
to those which can be manipulated without damage in either wire or 
perfusion myographs. Small resistance vessels which are the main 
determinants of peripheral vascular resistance are therefore excluded. In 
myography, it is not possible to assess whether thickening of the media 
is due to increased cell size or whether cells become polyploid or have 
divided. In the present study no vessels are excluded and the techniques 
have focussed on changes in DNA synthesis, cell number and ploidy.
Vascular smooth muscle cells grow slowly in vivo (216), and 
some previously applied techniques are suited to measuring changes 
over periods of hours and are inadequate to detect changes over a period
I
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of days (3, 158). In vitro techniques have drawbacks because tissues 
are separated from intrinsic growth factors and interactions with other 
cells. The present study has investigated whether All is a growth factor 
in vivo using the continuous infusion of bromodeoxyuridine over two 
weeks, a timecourse that allows for the slow progressive growth of 
blood vessels.
A further complication is that vasoactive hoimones like All may 
have dual effects on vascular morphology causing hypertrophy either 
directly by acting as a mitogen, or indirectly by increasing blood 
pressure. To overcome this problem, previous studies have examined 
the vascular effects of All in the presence or absence of other 
antihypertensive agents (126, 217, 218). This too is unsatisfactoiy since 
blood pressure lowering drugs might also directly affect smooth muscle 
cell growth rates (158) or have other secondary effects on humoral 
factors controlling growth. In the present study we have tried to 
dissociate the mitogenic effects of All from its effects on blood pressure 
by adapting rats to low and high dietary sodium.
Whilst low dietary sodium endogenously raises All levels, there 
is also the tendency for prolonged sodium restriction to reduce blood 
pressure (267). The dose of captopril given in the present study has also 
been shown experimentally to reduce blood pressure and simultaneously 
lower plasma angiotensin levels in rats (129).
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Materials & Methods:
The animal experiments described in Chapter 3a are the same for 
this chapter. Changes in deposition of proteoglycans, collagen and 
matrix proteins were assessed using special stains; Masson's trichrome, 
Alcian blue PAS and Methyl Blue Van Gieson. Refer to general 
materials and methods chapter..
Quantification: BrdUrd indices were obtained for a range of blood 
vessels in cross section. Medial area was calculated for the same blood 
vessels.
Results:
1) Histology:
Histological sections of the entire mesenteric bed contained U'ansverse 
sections of arteries, arterioles and veins. Only endothelial cells were 
identified in the intima. The media consisted entirely of smooth muscle 
cells in all vessels examined. By contrast, the adventitia contained 
fibrocytes, nerves, capillary and lymphatic blood vessels and a few 
mononuclear cells. Histological examination of sections treated with 
histochemical stains (see "special stains" Chapter 2) showed no 
alteration in the collagen, matrix protein or proteoglycan content of the 
vessel wall in any of the experiments.
2) DNA Synthesis:
All infusion increased DNA synthesis in the arterial tree by twofold in 
the endothelium of arterioles, and by threefold in the media and 
adventitia (Fig.3.11). Fig.3.12. shows that the number of BrdUrd- 
positive nuclei in the media of vessels of all sizes increased, indicating 
that DNA synthesis was not confined to resistance vessels. The effect of 
All infusion on BrdUrd uptake is shown in Fig 3.17.
Low dietary sodium increased BrdUrd indices by 2-3 fold in the 
endothelium, media and adventitia when compared with vessels from 
rats with a sodium supplement (Fig. 3.13). The effect of dietary sodium 
intake on the media of all vessel sizes is shown in Fig.3.18. The 
number of BrdUrd-positive nuclei was consistently higher in vessels 
irrespective of size in the low sodium group (Fig.3.14).
Treatment with captopril halved the BrdUrd index in the media 
and adventitia, but had no effect on the endothelial BrdUrd index 
(Fig.3.15). This effect was observed in arteries and arterioles of all 
sizes (Fig.3.16). The effect of captopril on BrdUrd uptake in all vessels
71
is shown in Fig.3.19. None of the treatments had any significant effect 
on DNA synthesis in venules or veins.
3) Analysis of Ploidy:
In all experimental groups, analysis of the histograms plotting the 
frequency distribution of nuclear DNA content indicated that the 
majority of smooth muscle cells were diploid in all sizes of vessels; 
there was an occasional tetraploid nucleus typical of cells undergoing 
proliferation, but the number of these was not significantly affected by 
any of the treatments. Representative histograms from mesenteric 
vessels from an All-treated rat and a control are presented in (Fig.3.20).
4) Vascular Morphometry and Cell Number:
Table 3.1. Summarises the effects of all treatments on medial vascular 
DNA synthesis, medial area and cell number as compared by t-test;
P <0.05, 0.01, 0.001. Data show mean ± S.E.M (n= 5, 6).
Angiotensin II Dietary Sodium Captopril
BrDurdIndex 
(% Staining)
All 37.4+1.7 *** 
Coil 10.9+1.4
Low Na 19.2±L7 ** 
High Na 6.9±0.8
Cap 3.1±0.7 ** 
Con 13.7+0.9
Medial Area
(/tin2)
All 14864+980 * 
Con 9414+1212
Low Na 9120±946 
High Na 8199±882
Cap 7285±704 
Con 10501±934
No.
Nuclei/Section
All 53.8+3.2 * 
Con 37±3.1
Low Na41.9±3.7 
High Na 34.6+2.9
Cap 34.5±2.8 
Con 54.7+5.7
No.NncIei
/UiiitArea
(mm^)
All 4350±230 
Con 5550+270
Low Na 5450+300 
High Na 4940±240
Cap 5550+280 
Con 5850+270
Angiotensin II Infusion:
All transeversely sectioned vessels were included in the analysis so that 
representative sampling of all order resistance vessels was assured. The 
size of blood vessels ranged from first to fifth order in All and control 
groups. Medial area was normally distributed and was compared by t- 
test. Medial areas in the All group, however, were greater for all sizes 
of vessel. To depict this effect gmphically, the medial area of each group 
were ranked separately in ascending order and arranged into centiles. 
The first centile from the control group was compared directly with the 
first centile from the treated group. The standardised rank order of All
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All treated vessels compared with those of controls is shown in 
Fig.3.21. At no point do the lines overlap suggesting that All affects 
vessels of all sizes. The extent to which medial area is affected by 
treatment is estimated in Fig.3.24. Although All has a pronounced 
effect on the media of all order resistance vessels, with increases in 
some resistance vessels up to 250%, All also caused a significant 
increase in the number of medial nuclei per cross-section of media 
(P<0.05; Fig.3.25). There was a tendency for fewer nuclei per unit area 
of media but this was not statistically significant (Fig.3.26).
Low Sodium:
The standardised rank order of vessels in both groups are shown in 
Fig.3.22 Although the medial area of vessels from low sodium rats 
tended to be slightly higher than those of the high sodium group, this 
effect was not statistically significant. The estimated increase in medial 
area is depicted in Fig.3.24 Dietary sodium did not significantly affect 
the number of nuclei per cross-section of media (Fig.3.25) nor the 
number of nuclei per pm^ of media (Fig.3.26).
Captopril:
The vessels ranked in order of medial area showed no significant effect 
of treatment (Fig.3.23). Treatment with captopril tended to reduce 
medial area (Fig.3.24), however this effect was not statistically 
significant. Similarly, the number of nuclei per cross section of media 
tended to be reduced with captopril but the effect was not significant 
(3.25) and there was no change in the number of nuclei per pm^ of 
media (3.26). The structure of veins was unaffected by any ti’eatment.
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D iscussion:
Tunica Media:
Two-threefold differences in DNA synthesis of vascular smooth 
muscle cells (VSMC) of resistance vessels of the mesenteric bed were 
observed in response to All infusion, captopril treatment or variations in 
dietary sodium intake. These effects are surprisingly large given firstly 
that changes in circulating AH concentrations caused by these treatments :are predicted to be modest (125) and also that increased plasma All 
levels are known to downregulate angiotensin receptors in vascular 
tissues (219) thereby, potentially, limiting responsiveness. However, 
the magnitiude of these differences have to be put in perspective.
Firstly, by infusing BrdUrd continuously over the entire period of 
treatment, DNA synthesis has been monitored for a longer time period 
than others have used routinely (156, 158). Secondly, apparent 
increases in BrdUrd labelling could be affected by changes in ceU death.
Apoptosis is a gene-regulated programmed event which is controlled 
separately from cell division. Unlike cell division, apoptosis leaves no 
trace after dead cells have been phagocytosed. The BrdUrd index would 
appear greater if cell division was unaffected but mature cells were 
dying at a faster rate. Thirdly, increased DNA synthesis does not 
necessarily result in cell division. VSMC's may become polyploid 
particularly in conductance vessels in hypertension (156). It should be 
noted that that the present BrdUrd index does not necessarily reflect cell 
division.
Assessing changes in structure of blood vessels depends on how 
the tissues are treated following experimentation. Perfusion fixation of 
blood vessels at pressure (e.g.lOOmmHg) is used to enable 
standardisation of lumen/wall ratio measurements. This standardisation 
is, however, arbitrary since perfusion may over or underestimate the 
intravascular pressure of the animal thus leading to collapse or 
distension of the lumen (167). The method that Short used to compare 
vessels from normotensive and hypertensive patients is better because 
although lumen diameter was a consideration, representative vessels of 
all sizes were included in the analysis. In this latter respect, the present 
studies are similar in that no vessel was excluded. This has two 
advantages; it obviates the need to standardise by lumen diameter and it 
includes smaller resistance vessels which myography studies tend to 
ignore. Using this approach, it was possible to identify a crucial 
difference between the effects of AH caused by exogenous infusion and
,:ï
those caused by raising endogenous AH concentration by dietary 
sodium restriction. Whereas All infusions increased medial area by up 
to two hundred and fifty percent in very small vessels, low sodium had 
no effect despite a twofold increase in DNA synthesis. All infusion 
caused a significant increase in the number of VSMC's per cross section 
of media and a decrease, albeit non-significant, in the number of 
VSMC's per unit area of media indicating that cell proliferation was 
possibly accompanied by increased cell size. On the other hand, given 
that there was no increase in extracellular matrix, low sodium caused an 
increase in the number of nuclei per unit area with no overall effect on 
medial area indicating cell division, but suggesting smaller individual 
VSMC's. The possibility that differences between the effects of 
exogenous and endogenous All are caused by polyploidy, has been 
excluded. VSMC's of mesenteric vessels of all sizes and all 
experimental conditions were predominantly diploid.
Morphologically, increased cell division caused by exogenous 
and endogenous AH has different consequences. Exogenous All caused 
vascular hypertrophy whereas endogenous AH had no effect on medial 
area. The increase could be explained by the mechanical effects of blood 
pressure on growth. Evidence for this is derived from studies in which 
smooth muscle cell stretching promotes the expression of some of the 
proto-oncogenes which induce growth (142) and blood pressure 
lowering drugs which either prevent or reverse vascular hypertrophy 
(126, 218). However, this evidence is controversial. Firstly, proto­
oncogenes are activated during stretch (142) and also in response to AH 
(144, 265), yet there was no evidence of hypertrophy following 
treatment with low dietary sodium. Assuming that All induced 
endogenously, in response to low dietary sodium, also stimulates proto­
oncogene expression, the lack of effect on hypertrophy makes a single 
role for proto-oncogenes difficult to reconcile. Secondly, the effects of 
blood pressure lowering drugs are difficult to interpret since they may 
interact directly with growth processes (158).
Neverthelesss, given the wealth of evidence from various 
sources that hypertension can itself cause hypertrophy (115, 220, 221), 
a direct effect of blood pressure cannot be excluded. The obvious 
explanation for the effects of endogenous and exogenous AH is that AH 
infusion increased blood pressure whereas low sodium diets tend to 
have the opposite effect. It is possible that other blood pressure-induced 
changes in blood vessel structure may be responsible for the increase in
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medial area such as cell hypertrophy or remodelling of existing smooth 
muscle cells. The former is more likely given that remodelling does not 
result in an increase in media mass but an alteration in lumen size due to 
rearrangement of the existing cells (118, 119).
It is also possible, however, that the vascular effects of low 
sodium are unrelated to changes in blood pressure since it has been 
postulated that growth effects of All are mediated via its effects on 
modulating renal sodium metabolism (222).
The effects of captopril are interesting in two respects. Firstly, 
the decrease in BrdUrd uptake would suggest that even under normal 
dietary conditions All tonic ally maintains rates of VSMC DNA 
synthesis. Secondly, the tendency for captopril to reduce medial area is 
more likely to be due to the negative effects of captopril on VSMC DNA 
synthesis (less cell renewal) rather than increased cell death since the 
number of cells per unit of media remained constant. This is in contrast 
to the effects of captopril in the adrenal gland where the zona 
glomerulosa was atrophied and the rate of DNA synthesis appeared 
unchanged as a result of increased cell death within the zone (see 
Chapter 3b). Although it is possible that captopril by lowering blood 
pressure reduces cell proliferation, the tendency for medial area to be 
reduced is more likely to be due to reduced cell proliferation caused by 
the absence of AU. Apoptosis induced by ACE inhibitiors remains to be 
investigated.
Endothelium:
Both All infusion and low dietary sodium increased DNA 
synthesis in endothelial cells of resistance arteries. This finding is novel 
and is surprising based firstly on the actions of All in promoting the 
release of vasoactive anti-mitogenic factors which cause endothelium- 
dependent relaxation such as endothelin-1(223) and prostaglandin 
(266). It is possible, however, that increased DNA synthesis occurs as a 
consequence of increased functional demand. Secondly, All inhibits 
coronary endothelial cell DNA synthesis in culture via the angiotensin II 
receptor AT2 (224). The mechanisms of All-induced growth of 
endothelial cells remains to be investigated. Captopril, on the other hand 
caused no change in DNA synthesis. This indicates first that endothelial 
cell DNA synthesis is not controlled exclusively by AH, or secondly that 
the tendency for reduced growth is compensated by other stimulatory 
factors such as the direct actions of ACE on bradykinin degradation
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(225). In vitro the presence of the endothelium reduces DNA synthesis 
in VSMC of isolated arteries (226). It is possible, therefore, that ACE 
inhibitors promote the release of endothelial ceU anti-mitogenic factors in 
vivo.
Adventitia:
The adventitia showed an increase in DNA synthesis when AU 
was raised by low sodium and by infusion. This is in accord with 
increased DNA synthesis in the adventitia of isolated arterial segments 
demonstrated by Daemen et al (1991) (227). Fibroblasts possess All 
receptors and also proliferate in response to All-stimulation in vitro (3).
In conclusion, All promotes DNA synthesis in all cell types of 
the mesenteric bed and is a potent mitogen for vascular smooth muscle 
cells in vivo. AH alone may not be able to cause vascular hypertrophy in 
vivo. A likely additional stimulus is blood pressure. Treatment with a 
low sodium diet also increases vascular smooth muscle cell DNA 
synthesis without vascular hypertrophy indicating that other humoral 
factors may be modulated by sodium intake. DNA synthesis in veins is 
unaffected by the renin-angiotensin system.
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C hapter 4: THE EFFECTS OF NITRIC OXIDE
SYNTHESIS INHIBITION ON DNA SYNTHESIS 
OF TISSUES: INTERACTIONS WITH THE RENIN 
ANGIOTENSIN SYSTEM
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Introduction:
The regulation of blood pressure by the renin-angiotensin 
system is influenced by many other factors. The actions of All, for 
example, are enhanced in the presence of other vasoconstrictors such as 
noradrenaline and PDGF and conversely, are attenuated by a variety of 
vasodilators such as atrial natriuretic peptide, prostaglandins and 
endothelium-derived relaxing factor (EDRF) (See Vanhoutte for review,
228). It has been shown that many endogenous vasoactive substances 
such as acetylcholine, bradykinin, histamine, adenine nucleotides, 
thrombin, substance P and serotonin (229) influence the release of 
EDRF to elicit endothelium-dependent vasodilation. Thus, EDRF has 
become established as an important mediator of cardiovascular and renal 
haemodynamics, neurotransmission and immunological responses 
(229).
Furchgott and Ignarro et al (230, 231) independently showed 
that EDRF had biological properties similar to nitric oxide (NO). Palmer 
et al (1987) (232) subsequently established that NO accounted for the 
biological activity of EDRF. NO is derived from L-arginine (233) under 
the control of two synthase enzymes; one which is expressed :|sconstitutively and depends on calcium ions, the second, which is
inducible, is calcium independent (229). ■
The use of NO synthase inhibitors such as the arginine 
analogues NG-monomethyl L-arginine and NG-nitro-L-arginine methyl 
ester (L-NAME) have increased our understanding of the role of NO in 
controlling haemodynamics and other neuroendocrine systems. L- 
NAME inhibits both the constitutive and the inducible NO synthases and 
has been used extensively to study the influence of NO on changes in 
blood pressure and the renin-angiotensin system (234, 235). Acute 
inhibition of the formation of NO caused vasoconstriction and marked 
increases in blood presssure in the normotensive Brattleboro and Long- 
Evans rats (236, 237). Chronic inhibition of NO synthase in adult rats 
causes hypertension and a rise in plasma renin activity (234, 236, 238).
This led to the hypothesis that NO synthase inhibition, by removing the
.:,i
vasodilatory effects of NO, potentiates the action of vasoconstrictors 
such as All which, in turn, cause hypertension (235). Treatment with 
the All receptor antagonist losartan, (234, 235) or the ACE inhibitor, 
enalapril, (235) either prevented or reduced hypertension caused by NO 
synthase inhibition. Longterm studies, however, have also shown that 
NO synthase inhibition results in a persistent form of hypertension 
involving the development of vascular hypertrophy (160). The 
mechanism by which vascular hypertrophy occurs in this experimental 
model is unclear but may involve the mitogenic actions of AIL In this 
chapter, time-dependent changes in vascular DNA synthesis following 
L-NAME treatment have been assessed using protocols established in 
previous chapters.
As well as the dose of NO synthase inhibitor, previous studies 
have shown that the duration of the experiment is important in 
determining when activation of the renin-angiotensin system is the cause 
of increased blood pressure (160). In the present study blood pressure, 
plasma renin activity and vascular DNA synthesis was measured in 
young normotensive Wistar-Kyoto rats after treatment for two or four 
weeks with L-NAME. The possible effects of L-NAME on renin 
secretoiy activity in the kidney and on a second angiotensin target 
tissue, the adrenal gland, are also considered.
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Materials and Methods:
NO synthase was inhibited in two experiments lasting two and 
four weeks. Two groups of six and two groups of eight, three-week 
old, male Wistar rats (40-50g), maintained on a regular diet were given 
either water containing L-NAME or tap water alone for two weeks and 
four weeks respectively. The calculated dose of 40mg/kg/day (0.2mg) 
was based on an average fluid intake of 20ml/kg/day. At the beginning 
of the two-week experiment, mini osmotic pumps conatining BrdUrd 
were implanted (see General Materials and Methods). In the four-week 
experiment, the mini osmotic pumps were implanted at the beginning of 
the third experimental week so that in both experiments, all animals 
received a two-week infusion of BrdUrd.
Cells were counted in the adrenal glands as described in Chapter 
2. In kidneys, however, four thousand cells were counted in the renal 
cortex to distinguish effects of treatment from normal growth of young 
animals. Adrenal zona glomerulosa widths were measured using an 
automated image analysis system.
I,
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Results:
Table 4.1: The effects of L-NAME treatment on various physiological 
variables. * p<0.05, "^*p<0.01, *^*p<0.001
Treatment Exp. Group Blood PR A Body Weight
Pressure (n g /A n gl/m l (g)
(mm Hg) /h)______ _______ _
L-NAM E
(2w k)
L-NAME
Control
128+7
116+10
0 . 12+0.1
1.63+0.7
157.5+16
162+14
L-NAM E
(4w k)
L-NAME
Control
161+5"'
134+5
0.78+0.2
1.36+0.6
190+10
199+23
i) Arteries:
The medial area of arteries ranged from 14 - 435xl0"4mm^ and 1.43 - 
211xlO"^mm^ in the two control groups and 18 - 357xlO"4mm^ and 
1.6x10"4 - 172x10'^mm^ in the groups treated for two and four weeks 
respectively with L-NAME. Between 158 and 238 arteries were 
measured in each group. As described previously, measurements from 
each group were ranked and compared (Fig. 4.1, 4.2). L-NAME did 
not significantly affect medial area in either experiment. There were no 
differences in the BrdUrd indices of the intima, media and adventitia 
between control and L-NAME groups after either two or four weeks 
(Figs.4.3, 4.4). At two weeks there was a tendency for DNA synthesis 
to be greater than at four weeks. However, this rate was not affected 
significantly by treatment with L-NAME. When the total number of 
medial nuclei/artery was plotted against the number of BrdUrd-positive 
nuclei/artery the slopes of the lines of experimental and control data at 
both two and four weeks were almost superimposable (Figs.4.5, 4.6). 
Together, these results show that, in spite of hypertension, L-NAME 
treatment has no significant effect on DNA synthesis in mesenteric 
arteries. Similarly, L-NAME has no effect on medial area or DNA 
synthesis in veins.
ii) Adrenal Glands:
At two weeks the width of the zona glomerulosa decreased in the L- 
NAME group (Control: 0.036+ 0.002mm; L-NAME: 0.029±0.002mm, 
p<0.02), while at four weeks the zona glomerulosa did not differ from 
the controls (Control: 0.048±0.002mm; L-NAME: 0.053±0.002mm).
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Adrenal gland weight corrected for body weight was unchanged after 
treatment with L-NAME. The BrdUrd index of epithelial cells in the 
zona glomerulosa was significantly lower in the L-NAME group at two 
weeks compared with controls (Fig. 4.7a). This effect is presented 
pictorially in figure 4.7b. At four weeks, however, there was a tendency 
for there to be more DNA synthesis in the glomerulosa following 
treatment with L-NAME although this did not reach statistical 
significance.(Fig 4.8a, b.).The zona intermedia showed little evidence 
of DNA synthesis and no significant differences in BrdUrd indices in 
treated and control groups in either experiment. The BrdUrd index of 
non-epithelial cells in the outer fasciculata was lower in the L-NAME- 
treated group after two weeks (P<0.01) but not at four weeks. These 
non-epithelial cells stained positively with an endothelial cell marker. 
There were no significant differences in epithelial cell BrdUrd uptake at 
either two or four weeks. DNA synthesis in the inner zona fasciculata 
was consistently low in all groups and of all cell types. L-NAME 
treatment for two or four weeks did not affect the BrdUrd index in either 
the inner zona fasciculata or the zona reticularis. In the medulla, the 
BrdUrd index of epithelial cells was lower in the L-NAME group at two 
weeks (P<0.01,). After four weeks however, the index was again 
similar to the controls.
iii) Kidney:
Kidney weights were unaffected by either period of treatment with L- 
NAME. After two weeks L-NAME, the number of renin-positive 
glomeruli/kidney decreased significantly (Fig 4.9). After four weeks, 
renin-secreting cells were not counted due to the lack of available anti­
renin antibody. BrdUrd uptake was predominantly in the inner cortex 
and was generally greater in the first two weeks than the second two. In 
glomeruli, the majority of BrdUrd uptake was in mesangial cells, 
although uptake in tubular epithelial cells, particularly in proximal 
tubules, was also high. There were no significant differences between 
control and treated groups in the glomeruli or tubules. After the first two 
weeks of L-NAME there was a significant increase in non-epithelial 
(interstitial) cell DNA synthesis (p<0.001; Fig 4.9) while at four weeks, 
the BrdUrd index was still higher than controls but not significantly 
(Fig. 4.10) .
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Discussion:
Theoretically, inhibition of NO synthesis could influence the 
structure and growth of the adrenal gland, mesenteric bed and kidney in 
several ways: i) directly, by antagonising antiproliferative effects of NO, 
ii) indirectly, in mesenteric arteries, by increasing vascular tone, iii) 
indirectly, by influencing the synthesis of other neuroendocrine factors. is.Since it is known that the development of hypertension following NO 
inhibition is a gradual process (160), one might also expect temporal 
differences in growth and development. These possibilities are 
discussed for each tissue in turn.
Kidney:
DNA synthesis increased in all cell types at two and four weeks 
but the increase was only significant in interstitial cells after two weeks 
of L-NAME. The general increase in DNA synthesis may be explained 
by the actions of L-arginine analogues on renal function. Chronic 
administration of L-NAME is known to elicit dose-dependent increases 
in glomerular capillary pressure and renal vasoconstriction resulting in 
increased diuresis (234, 235, 239). Therefore, DNA synthesis of the 
renal cell types may reflect increased functional activity of the kidney.
The results demonstrate temporal changes in the activity of the 
RAS. After two weeks, PRA and the number of renin secreting cells in 
the kidney were reduced. Suppression of the renin-angiotensin system 
may be a consequence of increased blood pressure which was observed 
during L-NAME treatment. This effect is surprising since NO is known 
to inhibit renin secretion directly in vivo (26) and one would perhaps 
expect an increase in renin secretion following inhibition of NO 
synthesis. The effects of NO inhibition after four weeks of L-NAME are 
different and cannot be compared directly with any other experiment,
PRA was within the normal range although hypertension was 
established. The increase in PRA from two to four weeks, despite the 
sustained negative influence of high blood pressure, may be explained 
by overriding changes in other stimuli, for example, sodium metabolism 
or blood volume. Renal damage caused by persistent high blood 
pressure (160) is also associated with activation of the RAS. However, 
in the present experiment, this explanation is unlikely since there was no 
evidence of hypertensive damage to the kidney.
Throughout L-NAME treatment, PRA was either suppressed or 'normal indicating that general increases in renal cell DNA synthesis 
following treatment with L-NAME are not mediated by systemic All.
I
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Even when All is raised by infusion, (see chapter 3a) DNA synthesis in 
most of the renal cell types is not raised significantly. The effects of L- 
NAME on renal cell growth might indicate a hitherto unrealised direct 
antiproliferative effect of NO on these cell types.
Changes in DNA synthesis of mesangial cells were not observed 
at either two or four weeks even although blood pressure was high in all 
rats at the end of treatment. As discussed in chapter 3a, increased blood 
pressure appears to be an important component for mesangial cell 
growth. However, the results from this experiment show that in the 
absence of All, pressure alone is not a sufficient stimulus. Mesangial 
cell growth possibly requires a combination of raised All and raised 
blood pressure.
Adrenal Gland:
Following treatment with L-NAME, DNA synthesis in the zona 
glomerulosa varied. After two weeks, the BrDUrd index was less than 
half of the controls whereas during the subsequent two weeks DNA 
synthesis appeared the same in control and experimental glands. If the 
effects observed during the first two weeks were due directly to the 
removal of NO, it is not clear why these effects were not sustained for 
the second two weeks. The acute stimulation of aldosterone synthesis is 
not influenced greatly by NO (240) and since reduced zona glomerulosa 
DNA synthesis is normally associated with reduced functional activity, 
it is unlikely that the changes in DNA synthesis are due to direct effects 
of NO. It is possible that effects of L-NAME at two weeks are the 
indirect consequence of an attenuation of NO-mediated blood flow 
through the adrenal gland (241). However, again this is unlikely since 
no effects were observed at four weeks. Furthermore, in vitro studies 
with perfused glands have shown that the minor influence that NO has 
on trophin-stimulated steroidogenesis (240; 241) are not due to the 
effects on flow (241). The fluctuations in PRA correlate closely with the 
effects observed in the zona glomerulosa. This argues strongly that the 
changes in growth observed in the zona glomerulosa are secondary to 
changes in the plasma levels of AH, the major stimulus for aldosterone 
secretion.
Inhibition of NO production by L-NAME resulted in reduced 
DNA synthesis in non-epithelial cells of the outer zona fasciculata. 
There were significant effects only during the first two weeks of 
treatment and no effect at any time in epithelial cells. These results differ
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from previous experiments (see chapter 3b) in which All raised by 
infusion and low dietary sodium or blocked by captopril had no effect 
on the non-epithelial cells of the outer zona fasciculata. It is unlikely, 
therefore, that AH is a stimulus for growth of these cells. Most of the 
non-epithelial cells in the adrenal gland identified positively with an 
endothelial marker. Since NO is produced predominantly from 
endothelial cells, it is possible that by blocking the synthesis of both 
inducible and constitutive NO synthase in these cells with L-NAME, 
DNA synthesis decreased. This effect was not observed at four weeks 
and it is possible that effects of treatment produce transient changes in 
cell growth with the subsequent loss of effect after four weeks. Another 
possible explanation for reduced DNA synthesis may relate to the 
established inhibitory effects of glucocorticoids on the NO synthase 
enzyme (242), however this is unlikely since neither L-arginine nor L- 
NAME had any significant effect on corticosterone secretion (241). The 
most likely explanation is the reduction in blood flow through the 
adrenal gland following treatment with L-NAME (241) which may alone 
remove the stimulus for growth. However, why this effect is specific to 
the outer zona fasciculata is uncertain. It is perhaps significant that in 
studies with radioactive microspheres to measure blood flow in the 
adrenal, most of the radioactivity accumulates in the region of the outer 
zona fasciculata.
The reduction in DNA synthesis of the adrenal medulla at two 
weeks may be due (i) directly to the removal of NO, (ii) indirectly to 
decreased medullary blood flow or (iii) indirectly by increased blood 
pressure. In previous experiments (see chapter 3b), the reduction in 
medullary cell DNA synthesis appeared to be due either directly to 
negative effects of All on cell giowth or indirectly as a result of 
increased blood pressure. These experiments clarify that reduced DNA 
synthesis can occur even when All levels are reduced, indicating that the 
reduction in DNA synthesis may occur indirectly to compensate for the 
rise in blood pressure. However, the effect was only apparent after two 
weeks and not after four weeks treatment.
Mesenteric Arteries:
NO inhibits vascular smooth muscle cell proliferation in vitro 
(146). One might expect, therefore, that L-NAME would promote DNA 
synthesis following removal of a growth inhibitor. However, treatment 
with L-NAME in vivo for two or four weeks had no significant effect
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on medial DNA synthesis or medial area. In a previous experiment (see 
chapter 3c), treatment with captopril and high dietary sodium decreased 
vascular smooth muscle cell DNA synthesis by twofold providing 
strong evidence that removal of All has negative effects on vascular 
smooth muscle cell growth. In this experiment, PRA levels were 
transiently suppressed during four weeks of treatment. One could 
anticipate, especially at two weeks, a corresponding reduction in DNA 
synthesis. Although the results fail to show any statistical significance, 
when PRA was reduced, there was a tendency for DNA synthesis to 
decrease in both the media and the adventitia. Similarly, when PRA was 
normal, medial DNA synthesis was very similar* to the conti’ol group. 
However, the lack of any real effect on blood vessels at two weeks may 
be explained by the combined effects of growth promotion and growth 
inhibition. The negative effects of low PRA counterbalanced by effects 
of growth promoters following NO inhibition. Alternatively, the lack of 
effect may be explained by the nature and timescale of the experiment. 
In previous experiments, treatment with L-NAME resulted in an 
immediate and sustained increase in PRA (160, 240). In the present 
experiments PRA was measured at the end of two and four weeks. 
However, if PRA rises initially as shown by others (160, 240) and then 
falls to low levels at two weeks as shown in the present experiments, 
the fluctuations in PRA may explain why DNA synthesis was not 
reduced significantly. This experiment is unlike the others described in 
that PRA following infusion with All or captopril would have been 
maintained constantly high or low.
Interestingly, blood pressure which was increased at two and 
four weeks did not, alone, appear to be a stimulus for growth of 
vascular smooth muscle cells, nor did it result in hypertrophy of any of 
the blood vessels measured. Similarly, in a previous experiment (see 
chapter 3c) All raised by low sodium increased VSMC DNA synthesis 
but did not cause vascular hypertrophy. This reinforces any previous 
conclusion that both raised All and blood pressure are required for the 
development of vascular hypertrophy.
In summary, two weeks of inhibition of NO synthesis by L- 
NAME, increased blood pressure with compensatory suppression of the 
RAS. Secondary effects of reduced PRA and All probably result in 
negative effects on DNA synthesis in the adrenal zona glomerulosa. 
Reduced DNA synthesis in zona fasciculata endothelial cells is possibly 
due to a combination of the negative effects of L-NAME on blood flow
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and the inhibition of glucocorticoids on NO synthase. Whereas previous 
studies have shown vascular smooth muscle to be sensitive to alterations 
in the RAS, DNA synthesis was not affected by suppression of the RAS 
with L-NAME. This lack of effect on vascular tissues may reflect the 
combined influence of the removal of a tonic anti-proliferative factor, 
NO, and the suppression of a potent mitogen, angiotensin II. Vascular 
hypertrophy over the timescales and with the dose of L-NAME indicated 
does not appear to be a feature of hypertension following inhibition of 
NO synthase.
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Chanter 5: THE EFFECTS OF GLUCOCORTICOIDS ON 
GROWTH OF VARIOUS TISSUES
Introduction:
The effects of glucocorticoid hormones on growth of tissues are 
complex. In vivo, stimulatory effects of low replacement doses of 
corticosterone (2p.g/d) are observed in underweight, adrenalectomised 
rats (243), whereas equivalent (supraphysiological) doses of the 
synthetic glucocorticoid, dexamethasone in intact animals reduce body 
weight gain (244). Furthermore, contrasting effects are seen depending 
on the tissue type and on the glucocorticoid concentration. For example, 
glucocorticoids induce apoptosis of thymic lymphocytes in vitro (245), 
promote adrenocortical atrophy (103) and inhibit growth hormone 
secretion by most secretagogues (246). Conversely, glucocorticoids 
repress apoptosis of the prostate (245), facilitate feeding and weight 
gain by acting directly on central nervous system tissues (243) promote 
growth hormone secretion (263) and proto-oncogene expression (247).
In addition to changes in growth, doses of glucocorticoids as 
low as 2p,g/d can alter neuromuscular function, salt and water 
metabolism and cause hypertension (82). It has been shown that the 
mechanisms of glucocorticoid-induced hypertension are not fluid- 
volume dependent (248) but blood pressure may be elevated by 
increased peripheral vascular resistance (249) caused by the potentiation 
of vasoconstrictors (250; 251) or inhibition of vasodilators (252). 
Lever, (111) has suggested that glucocorticoids can cause vascular 
hypertrophy.
Glucocorticoids interact with the renin-angiotensin system 
(RAS) in several ways. High concentrations of the naturally-occumng 
glucocorticoids, cortisol (man) and corticosterone (rat) have 
mineralocorticoid-type actions with marked suppression of the RAS
(253). Synthetic glucocorticoids, such as dexamethasone, have little 
mineralocorticoid activity. There are glucocorticoid receptor elements on 
many of the genes controlling the RAS and although angiotensinogen
(254), ACE (255) prorenin (256) and the AT-typel receptor (257) are 
dexamethasone-inducible, only exceptionally does plasma renin activity 
alter.
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In chapter 3C, vascular hypertrophy and hyperplasia resulted in 
response to infusion of All and high blood pressure. In chapter 4, nitric 
oxide synthase inhibition suppressed the RAS yet blood pressure was 
raised but there was no evidence of vascular hypertrophy. In this 
chapter, low dose dexamethasone has been given since it offers the 
opportunity to investigate the effects of blood pressure on blood vessel 
structure without significantly affecting plasma renin activity. 
Furtheimore, it provides an in vivo model to investigate the effects of 
glucocorticoids as potential growth factors/inhibitors for a variety of 
tissues.
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Materials and Methods:
Twelve adult male Sprague-Dawley rats (300g) had free access 
to rat chow and tap water ad libitum in a temperature-light-conti’olled 
room (21^0; 12 hours light, 12 hours dark). At day 0 the rats were 
intraperitonaelly anaesthetised (fentanyl citrate 67.5 ng/g, fluanisone 5 
pg/g, midazolam 2.5 pg/g) and silastic pellets releasing dexamethasone 
or vehicle were implanted subcutaneously at the back of the neck. 
Pellets were prepared by mixing dexamethasone with Silastic medical 
grade elastometer in a ratio of 1:40. After curing, pellet were cut into 
pieces which were calculated to release 4pg/d of dexamethasone. At the 
same time, osmotic minipumps releasing BrdUrd were also implanted as 
described previously (See Chapter 2). After two weeks treatment rats 
were killed and various tissues fixed for the immunocytochemical 
detection of BrdUrd-positive nuclei Two thousand cells were counted in 
each adrenocortical zone and in the adrenal medulla. In the kidney, one 
hundred glomeruli per rat were examined for the presence of renin 
immunostaining. A BrdUrd index for lipocytes was obtained by 
counting one hundred lipocytes surrounding mesenteric arteries.
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Results:
Table 5.1. Shows the effects of dexamethasone in rats: N.B. Thymus, 
adrenal gland and kidney weight are corrected for body weight. Data 
shown are means±SEM; *p<0.05, **p<0.01, ***p<0.001.
Dexam ethasone Control
Blood Pressure 
(mmHg)
176±7.5** 151.518.5
Plasma Renin Activity 
(ng/A ngl/m l/hr)
3.7±2.8 5.412.06
Plasma Corticosterone 
(nm ol/m l)
164+117 2041117
Body Weight
(R)
293±17* 31418
Thymus Weight 
(mg/lOOg)
92+12*** 177121
Adrenal Weight 
(mg/lOOg)
14.510.8 14.810.6
Kidney Weight 
(g/K g)
3.3710.01 3.2110.001
1) Morphometry:
1) Arteries:
Despite significantly increasing blood pressure, treatment with 
dexamethasone had no significant effect on the medial area of mesenteric 
arterioles (Fig.5.1), nor was there any evidence of vascular 
hypertrophy, 
ii) Kidney:
Dexamethasone tended to reduce the percentage of renin-positive 
glomeruli in the kidney, however this effect was not significant. (Fig. 
5.2).
2) DNA Synthesis:
i) Arteries:
The number of BrdUrd-positive nuclei in the media of 
mesenteric arterioles was low in both the controls and treated animals.
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approximately 2-4% compared with other experiments where control, 
adult Sprague-Dawley rats show approximately 10% of BrdUrd positive 
nuclei after two weeks. Examination of all blood vessels showed that 
the number of BrdUrd-positive nuclei was consistently low indicating a 
lack of effect of treatment,
ii) Adrenal Glands:
Treatment with dexamethasone caused a significant reduction in 
DNA synthesis within the epithelial cell population in the zona 
glomerulosa, outer zona fasciculata, reticularis and also reduced DNA 
synthesis in the catecholamine-secreting cells of the medulla. These 
results are represented in Fig (5.4). Photomicrographs of the effects of 
dexamethasone on the adrenal gland are shown in figures 5.5-5.6. 
üi) Kidneys:
DNA synthesis in the kidneys was mostly in cells of the inner 
cortex, aggregating as small foci. Treatment with dexamethasone 
increased the BrdUrd index in tubular cells (Fig. 5.3) but had no 
significant effect on either glomerular or interstitial cells, Fig (5.2).
iv) Thymus:
Most cells in the thymus of control rats stained positively for 
BrdUrd indicating rapid cell proliferation. The negative effects of 
dexamethasone on growth of thymic lymphocytes were so profound that 
measurements were not made. The effects are shown in Fig.5.7.
v) Adipose Tissue:
The BrdUrd index of fat cells surrounding the mesenteric blood 
vessels was reduced following treatment with dexamethasone (4.7±1; cf 
control 1.3±0.7 % BrdUrd-positive cells; p<0.01).
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Discussion:
Glucocorticoid treatment caused a significant reduction in body 
weight gain and profound inhibition of cell proliferation within a variety 
of tissues in vivo. Although it is not clear whether the phenotypic 
changes in tissues were a direct inhibitory effect of dexamethasone or an 
indirect consequence of the catabolic effects of glucocorticoids, the 
extent of the changes which occurred merit comment. The effects of 
treatment are therefore discussed for each tissue in turn.
Blood Vessels:
As expected, treatment with dexamethasone had no significant 
effect on the systemic renin-angiotensin system; any slight suppression 
of renin secretion may be compensated by increased angiotensinogen 
production. Despite a significant increase in blood pressure, 
dexamethasone had no effect on BrdUrd uptake into vascular smooth 
muscle cells nor did it affect medial area. The BrdUrd index of these 
cells was, in fact, much lower than that described in other studies (see 
Chapters 3C and 4). This is probably due to age, since the rats used for 
this study were older by several weeks and therefore gained weight 
more slowly than younger animals. Experimental and control animals 
were affected similarly. The lack of effect of dexamethasone on vascular 
structure suggests that blood pressure alone is not sufficient to cause 
hypertrophy and supports previous findings that the combined influence 
of a mitogen and hypertension are necessary.
Bearing in mind the dual catabolic and antiproliferative effects of 
glucocorticoids, one might expect a reduction in DNA synthesis of 
VSMCs of blood vessels. Indeed, weight gain was reduced significantly 
after two weeks. However, the lack of effect perhaps suggests that 
general growth inhibition is balanced by local factors which promote 
growth in certain tissues. Further studies on the direct effects of 
glucocorticoids on VSMC DNA synthesis are required to confirm this.
Adrenal Gland:
Reduced DNA synthesis was observed in the zona glomerulosa 
after treatment with dexamethasone. Although All is the major trophic 
factor for this zone, atrophy has been observed following 
hypophysectomy (2) indicating partial control of growth by the pituitary 
gland. Indeed, studies have shown that ACTH increases the size of the 
intracellular compartment of the glomerulosa cell (258). Doses of
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dexamethasone as low as 2jig/d inhibit ACTH secretion (259) and its 
activity can be assessed indirectly by measuring plasma corticosterone 
levels. In the present study, corticosterone levels were reduced slightly 
but the effect was not significant. The values observed are particularly 
high due to the effects of anaesthesia.
It has been suggested that doses of dexamethasone as low as 
3|ig/d directly inhibit adrenal cell growth (103). However, due to the 
local adrenal levels of corticosterone which are 100-1000-fold greater 
than elsewhere in the body (260) low doses are unlikley to significantly 
affect net glucocorticoid activity within the adrenal gland. The present 
study suggests that the negative feedback effect of dexamethasone on 
ACTH secretion causes a reduction in adrenocortical DNA synthesis and 
indicates that ACTH helps to maintain the zona glomerulosa in vivo.
Dexamethasone had no effect on the zona intermedia, indicating 
that the effects on growth are selective within zones. In previous studies 
(See Chapter 3b), DNA synthesis was low in the intennedia and was 
unaffected by manipulations of the RAS. Taken together, these studies 
do not support the zona intermedia as a novel stem cell zone as 
suggested by others (81).
Responses of the zona fasciculata to dexamethasone varied. 
Decreased DNA synthesis in the outer zona fasciculata is probably due 
to reduced ACTH since it is the major stimulus for corticosterone 
secretion and is the major trophic factor for the zona fasciculata. This 
study suggests that removal of this trophic factor involves reduced outer 
zona fasciculata cell proliferation in vivo.
Previous studies have provided evidence that inner zona 
fasciculata cells migrate from the outer fasciculata (93). One might 
therefore expect that the BrdUrd index in the inner part of the zone 
would reflect that of the outer zone. Since there was no effect of 
dexamethasone in the inner zona fasciculata, two possibilities are 
suggested. Firstly, that reduced ACTH has a negative effect on inner 
cell growth but decreased proliferation is compensated by increased cell 
death. In this instance, the BrdUrd index would remain constant 
although zonal atrophy would occur. This explanantion is unlikely since 
there was no evidence of atrophy within the zone or decreased adrenal 
gland weight. The second explanation is that the BrdUrd-labelled cells 
in the inner zona fasciculata may be a different population of cells from 
those in the outer zona fasciculata. If proliferation of these inner zone 
cells is not controlled by ACTH, then dexamethasone would have no
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effect. The differential effects in the zona fasciculata again demonstrate 
that the effects are specific to selected populations of cells suggesting 
that direct effects of dexamethasone are unlikely. These results highlight 
the independence of zones in maintaining cell populations.
Changes in the reticularis are also interesting. This zone has 
been identified as the zone in which cell death occurs. However, from 
our present observations and those in chapter 3b, DNA synthesis also 
takes place. Cell proliferation and death are not incompatible and both 
will influence the BrdUrd index. Since dexamethasone has previously 
been shown to cause apoptosis in the zona reticularis, it would appear 
that there is a population of cells which are sensitive to the mitogenic 
effects of ACTH and possibly of All within the zona reticularis.
Reduced DNA synthesis in the adrenal medulla may be due to 
the inhibitory effects of dexamethasone, however, similar effects have 
been observed in the medulla following treatment with factors which 
raise blood pressure (see Chapters 3b & 4). These inhibitory effects are 
most likely to compensate for the increase in blood pressure.
Kidney:
Dexamethasone tended to reduce DNA synthesis in most of the 
renal cell types but increased growth of tubular cells.The overall lack of 
effect of dexamethasone on kidney weight perhaps reflects this mixed 
response. The differential effects of treatment again suggest a 
combination of various factors in the regulation of growth. In mesangial 
cells, despite increased blood pressure, there was no effect of 
dexamethasone indicating that blood pressure alone is not a sufficient 
stimulus for growth of these cells. The tendency for dexamethasone to 
reduce DNA synthesis in interstitial and glomerular cells points to either 
direct inhibition or increased catabolism. The increase in tubular cell 
DNA synthesis may be explained by the direct actions of glucocorticoids 
on tubular cation exchange (261). The activity of the Na/H antiporter in 
tubular cells is known to be increased with glucocorticoid hormones. 
Intracellular alkalinisation is known to be a trigger for cell growth. The 
overall lack of effect of dexamethasone on the kidney reflects the 
susceptibility of some tissues to changes in growth relative to others and 
provides evidence for the multifactorial regulation of growth of many of 
the ceU types.
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Lymph Node and Thymus:
The most notable effects of treatment with dexamethasone were 
observed in the B and T lymphocyte populations where DNA synthesis 
was reduced by up to ninety percent. In addition, thymus weight was 
reduced providing evidence firstly that low dose dexamethasone is an 
antiproliferative factor for these cells, and secondly, that they are 
controlled predominantly by glucocorticoids since there appeared to be 
little or no protection from factors which promote growth. Somatic cell 
and molecular genetic studies on lymphoid cell lines have established 
that intracellular glucocorticoid receptors are the mediators of 
glucocorticoid evoked apoptosis (245). Evidence from the present study 
suggests that reduced cell proliferation is a major component of the 
thymolytic activity of low doses of glucocorticoid hormones. The extent 
to which apoptotic processes contribute to reduced thymus weight in 
vivo remains to be determined.
Adipose Tissue:
Within adipocytes, glucocorticoid receptors mediate the 
breakdown of intracellular lipid by increased lipase activity. There is 
some controversy, however, as to whether lipocytes proliferate or 
whether existing lipocytes merely change in size in response to changes 
in metabolism (262), The effects of glucocorticoids on reducing DNA 
synthesis suggests firstly that lipocytes synthesise DNA in vivo and 
secondly that DNA synthesis of these cells is controlled, at least in part, 
by glucocorticoids. Reduced lipocyte proliferation partially explains the 
catabolic effects of glucocorticoids and lack of weight gain in rats.
In conclusion, treatment with dexamethasone caused a 
significant reduction in DNA synthesis in most of the cell types studied. 
This effect was most apparent within the thymus and lymph node 
indicating that glucocorticoids are potent antiproliferative factors for 
these cells in vivo. The effects on the adrenal cortex are likely to be due 
to the negative effects of dexamethasone on ACTH secretion. In the 
kidney, the combination of reduced DNA synthesis and increased DNA 
synthesis imply that glucocorticoids are both stimulate and inhibit cell 
growth. Dexamethasone has no obvious effect on DNA synthesis of 
blood vessels nor on medial area. Blood pressure alone is not a stimulus 
for vascular hypertrophy in vivo.
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General Conclusions
Throughout two weeks of infusion of BrdUrd, the patterns of 
DNA synthesis in blood vessels, adrenal gland and kidney were similar 
within control groups indicating consistency of the infusion technique. 
The rates of DNA synthesis were affected by age and weight; 
prepubertal rats showing a tendency for DNA synthesis to be greater 
than adult rats. In turn, tissues of older rats (those greater than 250g) 
tended to show less DNA synthesis. There were between-tissue 
variations in growth. Uptake of BrdUrd was greatest in the 
lymphoreticular tissues such as the lymph node and thymus and least in 
VSMCs of blood vessels. The treatment period was sufficient to detect 
changes in DNA synthesis of all cell types and was particularly suited to 
those which have a slower turnover.
This study has shown that the RAS, in addition to its role in the 
regulation of blood pressure, promotes DNA synthesis and growth of 
many of its target tissues in vivo. The actions of All appear to be 
specific for many cell types which possess angiotensin II receptors. în 
vivo. All promotes proliferation of vascular smooth muscle cells of all 
sizes of blood vessels independent of blood pressure changes and is 
also mitogenic for specific adrenocortical cells. Contrary to expectation, 
raised systemic All and renin/AH raised locally did not promote growth 
of any of the cell types in the kidney, except mesangial cells. However, 
these cells only synthesised DNA when subjected to a combination of 
raised blood pressure and increased AH. This suggests that growth of 
some cells may require additional stimulation, possibly blood pressure. 
Other renal cell types which grow in response to AH in culture do not 
respond similarly in vivo. This may be dose-related or due to variations 
associated with in vitro conditions.
This study highlights the variation in responsiveness of smooth 
muscle cells which are phenotypically different to growth stimuli. 
Mesangial cells, renin-secreting cells in the renal arteriole and smooth 
muscle cells within blood vessels all showed variations in 
responsiveness to All. Whilst stimulating DNA synthesis in vascular 
smooth muscle, All had no effect on the renal arterioles and stimulated 
mesangial cells only in the presence of raised blood pressure. In 
isolation, blood pressure was not a sufficient stimulus for growth in any
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of these cells. However, All and blood pressure combined increased 
medial thickening in a large proportion of mesenteric resistance vessels.
This data suggests that drugs which have the capacity to reduce AU and 
blood pressure will produce the most potent effects in patients with 
severe hypertension.
More importantly, this study has also identified that the 
regulation of cell growth in vivo is complicated by the interaction of the
„;i4.RAS with other physiological systems. The interaction of the RAS with g
the L-arginine derived NO system and with glucocorticoids induces #|
many changes in growth of tissues, many of which are difficult to 
interpret without having a full understanding of the individual effects.
This study suggests largely that mechanisms which promote growth are 
often counterbalanced by factors which inhibit growth and the 
interactions between stystems are possibly one way in which tissues are 
protected from becoming either depleted or overstimulated.
Prospects for Future Work:
This project has opened many avenues for potential research.
Consistently in these experiments the growth effects in blood vessels 
and in the adrenal gland have been attributed to specific effects of AIL 
The concept that steroid hormones are also involved in the regulation of 
cell growth, raises the possibility that aldosterone and an as yet 
unidentified product of the zona reticularis may also be involved in the 
control of growth of the cardiovascular system. Bearing in mind that All 
stimulated growth of the zona glomerulosa and zona reticularis cells, 
mitogenic actions of the steroids produced by these cells cannot be 
excluded. Investigating the effects of the androgens and oestrogens in 
vivo would be complicated by the lack of available antagonists, 
however, the effects of aldosterone could be investigated directly by
adrenalectomy or by administration of spironolactone, an aldosterone 
antagonist. Furthermore, the interactions of All with low sodium merit 
further investigation, since the vascular responses to AH are modulated 
in the presence of sodium. Further study into the AT receptors which 
control the growth responses is required.
A more diverse study to identify further which growth factors 
are involved in cardiovascular growth and more importantly, the 
mechanisms of growth is necessary. This would involve more 
comprehensive investigation on the actions of local renin-angiotensin 
systems and analysis of the expression of growth factors in vivo.
s
The concept of genetic variation is an important consideration in 
further investigating the control of growth by the RAS. Genetic strains 
of rat with relative insensitivity and hypersensitivity to AH are available. 
Moreover, many of the 'early genes' or proto-oncogenes have been 
identified, however not many studies have yet been able to ascribe the 
expression of these genes with specific physiological functions. Further 
characterisation of these genes will probably be useful in investigating 
the mechanisms of cardiovascular disease.
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A P P E N D I X  
Appendix I: Alkaline Phosphatase Substrate
Method: Alkaline phosphate substrate is extremely light and heat 
sensitive.
1. Dissolve Napthol AS TR phosphate in a few drops of dimethyl 
formamide.
2. Dissolve levamisole in veronyl acetate buffer and add tétrazolium salt 
(fast blue B or fast red violet).
3. Add Napthol AS TR phosphate- solution becomes cloudy.
4. Filter solution, refrigerated in the dark.
5. Add clear solution to sections for 10 minutes.
BrdUrd positive nuclei appear dark blue or red depending on the dye 
used.
Appendix II: Slide Coating
Concentrated poly-L-lysine solution was diluted 1:10 with deionised 
distilled water.
1. Place uncoated, clean slides in a clean rack.
2. Immerse rack in solution for 5 minutes.
3. Drain and dry sections in oven at 60°C for one hour.
Appendix HI: 0.5 % Hydrogen peroxide (H2O2) and methanol.
Ipart H2O2/ 60 parts methanol.
Appendix IV: Diaminobenzidene (DAB)
Stock Solution: The vial containing diaminobenzidene is flushed clean 
with dimethyl formamide to dissolve the DAB. The contents of the flask 
are reconstituted with tris buffer pH 7.6 to make to a final volume of 
25ml. DAB is dissolved fully overnight in the dark and aliquoted into 
200|al quantities and frozen at -70°C.
Working solution: Allow vial to come to room temperature. Add 50ml 
of 0.1 M imadazole, 450ml 0.05M Tris/HCl buffer and 250|il of 30%
H2O2.
Tissue sections taken from distilled water are submerged in working 
solution for 8 minutes. Renin appears dark brown.
:
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Appendix V: Counterstaining with haematoxylin 
All sections were counterstained by agitating in 0.1% Mayer's 
Haematoxylin diluted in distilled water for 2 minutes.
Appendix VI: Alcian Blue PAS 
Solutions:
1% Alcian Blue in 3% Acetic Acid,
1% Aqueous Periodic Acid 
Schiffs Reagent 
Technique:
(1) Take sections to water
.(2) Treat sections with the alcian blue solution for 5 minutes
(3) Wash well in distilled water
(4) Treat with the periodic acid solution for 2 minutes
(5) Wash well in distilled water. Then wash in Schiffs reagent for 8 
minutes
(6) Wash in running water for 10 minutes
(7) Stain the nuclei with Mayer's haematoxylin solution. Differentiate 
and blue.
(8) Dehydrate, clear and mount.
Results: 
acid mucins -blue ■i;:;neutral mucins -red
mixtures -purple
nuclei -pale blue
Appendix VII: Methyl Blue van Gieson technique 
Solutions:
Modified van Gieson's Stain
0.05% Aqueous Methyl Blue - 50ml
0.1% Acid Fuchsin in Saturated Aqueous Picric Acid - 50ml 
Mix, then add
Glycerol - 10ml
Saturated Aqueous Lithium Carbonate - 0.5ml
Technique:
(1) Take sections to water
(2) Stain nuclei with an iron haematoxylin solution. Differentiate and 
blue.
(3) Stain with modified van Gieson's solution for 2 minutes.
125
J"
126
■ï
(4) Wash in 1% acetic acid solution for 2 minutes.
(5) Dehydrate, clear and mount.
Results;
nuclei - brown-black
reticulin & young collagen - blue 
mature collagen - red
red blood cells, muscle - yellow
Appendix VIII: Masson's Technique 
Solutions:
Ponceau-acid fuchsin solution 
1% aqueous phosphomolybdic acid 
1% light green diluted 1:10 with distilled water 
Technique:
(1) Take sections to water
(2) Stain nuclei with an iron haematoxylin solution. Differentiate and 
blue. Wash in water.
(3) Treat with the ponceau acid-fuchsin solution for 2-3 minutes.
(4) Wash in water and differentiate in the phosphomolybdic acid 
solution (between 5-15 minutes at room temperature).
(5) Wash well in water.
(6) Counterstain with light green solution for 1 minute.
(7) Wash, dehydrate, clear and mount.
Results:
nuclei -blue-black
muscle - red
connective tissue - green.
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